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Abstract 
NC-1059 is a synthetic channel-forming peptide that provides for ion transport across, and 
transiently reduces barrier integrity of, cultured epithelial monolayers derived from canine 
kidney (MDCK cells; Broughman, J. R. et al; Am J Physiol Cell Physiol 286: C1312-23). In this 
first study experiments were conducted to determine whether epithelial cells derived from other 
sources were similarly affected. Human (T84, Calu-3) and non-human (IPEC-J2, PVD9902) 
epithelial cells derived from intestinal (T84, IPEC-J2), airway (Calu-3), and genitourinary 
(PVD9902) tissues were grown on permeable supports. Ion transport and barrier function were 
assessed electrically in a modified Ussing chamber. Basal short circuit current (Isc) was typically 
less than 3 μA cm-2. Apical NC-1059 exposure caused, in all cell types, an increase in Isc to >15 
μA cm-2, indicative of net anion secretion or cation absorption that was followed by an increase 
in transepithelial conductance (gte in mS cm-2; T-84, 1.6 to 62; PVD9902, 0.2 to 51; IPEC-J2, 0.3 
to 26; Calu-3, 2.2 to 13). NC-1059 induces a concentration dependent change in the Isc and gte 
across these epithelia. The results in all cases were consistent with both a transcellular and a 
paracellular effect of the peptide. NC-1059 enhanced permeation of dextrans ranging from 10 
kDa to 70 kDa across all epithelia tested. These results document an effect of NC-1059 on the 
paracellular route of epithelial barriers. Immunolabeling, confocal microscopy and 
immunoblotting methods were used in a second study to assess the molecular changes associated 
with increased paracellular permeability. NC-1059 induced a substantial reorganization of actin 
within 60 minutes of exposure. Confocal microscopy revealed that the changes in actin 
organization were accompanied by a pronounced change in the abundance and distribution of 
 tight junction proteins occludin and ZO-1. Immunoblotting results suggest a time and 
concentration dependent effect on cellular abundance of these tight junction proteins.  The 
effects on gte and junctional proteins are transient with > 85% of recovery in 24 hours post 
exposure and full recovery within 48 hours. The reversible modulation of the epithelial tight 
junctions has therapeutic potential to increase the efficiency of drug delivery across barrier 
membranes.  
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(PVD9902) tissues were grown on permeable supports. Ion transport and barrier function were 
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to 26; Calu-3, 2.2 to 13). NC-1059 induces a concentration dependent change in the Isc and gte 
across these epithelia. The results in all cases were consistent with both a transcellular and a 
paracellular effect of the peptide. NC-1059 enhanced permeation of dextrans ranging from 10 
kDa to 70 kDa across all epithelia tested. These results document an effect of NC-1059 on the 
paracellular route of epithelial barriers. Immunolabeling, confocal microscopy and 
immunoblotting methods were used in a second study to assess the molecular changes associated 
with increased paracellular permeability. NC-1059 induced a substantial reorganization of actin 
within 60 minutes of exposure. Confocal microscopy revealed that the changes in actin 
organization were accompanied by a pronounced change in the abundance and distribution of 
tight junction proteins occludin and ZO-1. Immunoblotting results suggest a time and 
 concentration dependent effect on cellular abundance of these tight junction proteins.  The 
effects on gte and junctional proteins are transient with > 85% of recovery in 24 hours post 
exposure and full recovery within 48 hours. The reversible modulation of the epithelial tight 
junctions has therapeutic potential to increase the efficiency of drug delivery across barrier 
membranes.  
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CHAPTER 1 - Background 
Overview:  
This section will start at the level of the epithelium and will focus on the pathway between cells 
(i.e., the paracellular pathway) that solutes and solvent might traverse to move between mucosal 
(apical) and serosal (basolateral) solutions. The paracellular pathway will be examined first from 
an electrical perspective to provide a foundation for the measurement techniques employed in 
this research project. A morphological and molecular perspective of the paracellular pathway 
will then be presented. The types of cell-cell contacts in epithelial tissues, the types of proteins 
that are involved in forming these contacts and their functions will be described. The final 
component of this section will introduce mechanisms that are employed to modify the 
paracellular pathway and this section will include an introduction to synthetic channel-forming 
peptides that were discovered and initially described by members of this laboratory. 
Epithelia: Epithelial tissues are made up of tightly packed cells that are arranged in one or 
more layers that line internal and external body surfaces including the skin, nasopharyngeal, 
gastrointestinal, genitourinary tracts and organs of the body. Epithelial cells have diverse shapes, 
sizes, and morphological characteristics such as the presence of cilia, which give them unique 
capabilities. Epithelial layers, irrespective of location serve as selective barriers to the flow of 
molecules. These tissues protect the underlying tissue from exposure to harmful chemicals and 
organisms and also maintain the composition of the compartments that they separate. There are 
two major routes for the movement of solutes across epithelial layers; transcellular and 
paracellular. The transcellular route allows the movement of hydrophobic molecules. Epithelial 
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cell membranes have a variety of channels, carriers and pumps that help in the movement or 
uptake of hydrophilic molecules that would otherwise be excluded. The paracellular pathway 
also shows charge and size selectivity and therefore limits the movement of most hydrophilic 
molecules. The movement of charged solutes across an epithelial barrier can be measured 
electrically with a scheme as depicted in Fig 1.1. 
 
 
Figure 1.1:  Representation of an epithelium as a simplified electrical circuit. 
Two pathways for solute movement across epithelia are depicted, i.e., transcellular and 
paracellular. The electrical circuit represents the epithelium as a series of resistors. M denotes the 
mucosal or apical node and S the serosal or basolateral node. Ra and Rb are the resistances across 
apical and basolateral membranes, respectively and Rtj and Rics are the resistances across the 
tight junctions and lateral intercellular space, respectively. C indicates the cellular node. (The 
figure is adapted from, Powell, 1981) 
 
 
Transepithelial electrical conductance (gte) is commonly used as a measure of epithelial barrier 
integrity. The epithelium shows characteristic electrical properties and can be modeled 
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mathematically as an electrical circuit. In  Fig. 1.1 is a simplified representation of this electrical 
circuit (Powell, 1981). In the circuit, the apical and basolateral membrane resistances, Ra and Rb 
are in series and Rc is the transcellular resistance = Ra + Rb. The paracellular resistance Rs, is the 
sum of the tight junction (Rtj) and intercellular space resistances (Rics) (i.e., Rs = Rtj + Rics). Rs is 
modeled in parallel with Rc. Hence the transepithelial resistance (Rte) can be determined (i.e., Rte 
= (Rc)(Rs)/Rc + Rs). Since conductance (g) is inversely proportional to the resistance (according 
to Ohm’s law g=1/R) the information provided in Fig. 1.1 can also be presented in terms of 
electrical conductance, g. The transcellular conductance, gc is the sum of the reciprocals of the 
apical membrane conductance (ga) and the basolateral membrane conductance (gb). gs represents 
the paracellular conductance, which likewise is the sum of the reciprocal of the conductance 
across the tight junction (gtj) and the conductance associated with the lateral intercellular space 
(gis). gte, which can be readily measured in the laboratory, is the sum of gc and gs. In commonly 
studied epithelia the gc is small as compared to the gs and hence a dramatic change in gte most 
often reflects an increase in gs (Cereijido & Anderson, 2001). 
Several factors influence gte including the density of the paracellular route, which depend on size 
and shape of the individual epithelial cells as shown in Fig. 1.2 (Cereijido & Anderson, 2001). 
Hence, epithelia that differ in morphology can vary greatly in basal gte. Epithelia that have a high 
gte are called “leaky” and epithelia with a low gte are referred to as “tight” (Cereijido & 
Anderson, 2001). In several epithelia, large changes in gte can reflect a change in gs, and are an 
indicator that the integrity of the tight junctions and intercellular spaces as a barrier to solute 
flow are compromised. The integrity of the paracellular route is maintained by a complex 
network of junctional and cytosolic proteins. 
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Figure 1.2: Epithelial cell shape can influence the density of intercellular spaces and hence 
gte. 
As the ratio of lateral surface area to cross sectional area increases, density or linear amount of 
intercellular space per unit area of epithelium will increase (Cereijido & Anderson, 2001).  
 
 
 
Ultrastructure of the intercellular space: Electron microscopy images of intercellular 
junctions in various epithelia were described by Farqhuar and Palade as “tripartite complexes” 
that were divided into three intercellular regions from apical to basolateral: zonula occludens 
(tight junctions); zonula adherens (adheren junctions); and macula adherens (desmosomes; Fig. 
1.3) (Farquhar & Palade, 1963). In observations made with electron micrographs of several 
different tissues (Farquhar & Palade, 1963) the zonula occludens extended from apical to 
basolateral by 0.2 to 0.5 μm (Fig. 1.4). The electron micrographs also revealed that the 
intercellular lumen is wider at the level of the zonula adherens, than at the zona occludens Fig. 
1.4A. The overall adheren junction appears to be 25 nm wide and extend by ~ 0.3 to 0.5 μm 
along the intercellular space (Farquhar & Palade, 1963). The desmosomes lie below the adheren 
junction and are surrounded by filaments called intermediate filaments (Fig 1.3 and 1.4A) 
(Farquhar & Palade, 1963). 
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Figure 1.3: An idealized perspective of cell-cell contacts and the intercellular space. 
Tight junctions form a continuous band between adjacent cells near the apical boundary of 
contact. Adheren junctions lie below (i.e., basal) to the tight junctions and are followed by the 
desmosomes, which are associated with intermediate filaments. Additionally the adjoining cells 
communicate through gap junctions. (Adapted from Molecular Cell Biology, Lodish et al., 
1995). 
 
 
Ultrastructure of the tight junctions: Farqhuar and Palade named the tight junctions zonula 
occludens, which translates as “closing belt” in Latin, based on their observations that, at the 
level of the tight junctions, the lumen was extremely narrow, being only ~ 11 nm wide (Farquhar 
& Palade, 1963). Electron micrographs of tight junctions revealed two outer membranes and two 
inner membranes that appose each other but at some regions, the inner membranes were so close 
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together that they appeared as one membrane. These regions of focal contacts are informally 
called “kisses” (Fig. 1.4B) (Lodish et al., 1995). Freeze fracture replicas of the “kisses” show a 
network of anastamosing strands that are partitioned onto the protoplasmic leaflet (P face) of the 
freeze fracture and show corresponding grooves on the exoplasmic leaflet (E face; Fig. 1.5) 
(Staehelin, 1973). Immunogold labeling of the freeze fracture tissue shows that integral 
membrane proteins that constitute a part of the junctional multimolecular complex are localized 
along these strands, which are mostly on the P face. The distribution of these strands onto the P 
face is attributed to strong links of these integral membrane proteins to cytoplasmic and 
cytoskeletal proteins (Cereijido & Anderson, 2001). 
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Figure 1.4: Electron micrographs of intercellular spaces between epithelia. 
Electron micrograph of intercellular spaces between epithelia showing tight junctions (TJ), 
adheren junctions (AJ) and desmosomes (DS) along with the intercellular space. Microvilli (Mv) 
extend from the apical face of the cells. Panel B is an enlargement of the tight junctions where 
the arrowheads indicate points of focal contacts or “kisses”. Scale bar is 200 nm in Fig. A and 50 
nm in Fig. B (Adapted from Tsukita, Furuse & Itoh, 2001) 
 
 
 
 
 
 
Figure 1.5: Freeze fracture replicas of epithelial cell focal contacts or tight junctions. 
Freeze fracture replicas of tight junctions between epithelial cells clearly showing ‘strands’ or 
‘kisses’. The left figure is the P face and the right is the E face with strands in the P face and 
corresponding grooves in the E face (Figure adapted from Staehelin, 1973). 
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Tight junctions:  
Tight junctions are “multimolecular complexes” that include integral membrane proteins, plaque 
proteins and several cytosolic proteins (Fig. 1.6). 
 
 
 
Figure 1.6: Organization of junctional proteins and the molecules involved in their 
regulation. 
The figure represents the organization of proteins at the tight junctions. a single focal contact or 
“kiss” is depicted. The transmembrane proteins occludin and claudins associate with with the 
plaque proteins ZO-1, ZO-2 and ZO-3. The figure also shows actin, which binds the plaque 
proteins. (Figure modified from Mitic & Anderson, 1998). 
 
 
The major integral membrane proteins, occludin, claudin family proteins and junction adhesion 
molecules (JAM), are localized at the most apical region of the paracellular route. The plaque 
proteins serve as a link between the integral membrane proteins and the actin cytoskeleton, 
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predominantly through specific binding sequences known as PDZ domains. The major plaque 
proteins are ZO-1, 2 and 3 (Fig. 1.6), multi-PDZ domain protein-1 (MUPP-1), membrane 
associated guanylate kinase inverted proteins (MAGI-1, 2 and 3), and the partitioning defective 
proteins (PAR-3 and 6) (Schneeberger & Lynch, 2004). The tight junctions also include a large 
number of cytosolic molecules including tumor suppressors, regulatory proteins and 
transcriptional factors. These cytosolic proteins interact directly or indirectly with the plaque 
proteins.  
Transmembrane proteins at the tight junctions:   
Occludin: Occludin was first identified in rat liver extract and found to be localized at the tight 
junctions (Furuse et al., 1993). Immunoblotting has shown several bands for occludin that range 
in mobility from 58 kDa to 82 kDa based on degree of phosphorylation (Sakakibara et al., 1997). 
The predicted topology of the protein, as shown in Fig. 1.7, reveals that the N-terminal half has 4 
membrane spanning regions and the C-terminus is a large cytosolic domain. 
 
 
Figure 1.7: Predicted membrane topology of occludin. 
M1 –M4 represent the membrane spanning domains of occludin. (Modified from Furuse et al., 
1993). 
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A second occludin isoform, occludin 1B, contains 56 additional residues in the amino-terminal 
cytosolic tail and exhibits a similar expression pattern (Schneeberger & Lynch, 2004). 
Regardless of isoform, the membrane spanning regions, M1-M2 and M3-M4, form extracellular 
loops (Fig. 1.7). In the M1-M2 loop 25% of the residues are tyrosine and 36.4% residues are 
glycine. In the M3-M4 loop 18% of the residues are tyrosine. These tyrosine residues are 
potential targets for several protein kinases (Furuse et al., 1993). It is suggested that occludin 
exists in a hyperphosphorylated form at the tight junctions (Sakakibara et al., 1997). Most of the 
C-terminal half is conserved among species and has several charged residues. The midsection of 
the cytoplasmic domain is populated by basic residues whereas the tip of the C-terminus is not 
conserved and has several acidic residues. The C-terminus is a target for protein kinases. The tip 
of the C-terminus is involved in protein-protein interactions with guanlylate kinase (GUK) 
domains of ZO-1, ZO-2 and ZO-3, F-actin and cingulin (Furuse et al., 1994; Li et al., 2005; Paris 
et al., 2007). The C-terminus of occludin is proposed to be responsible for the localization of 
occludin at the tight junctions (Furuse et al., 1994). The role of occludin at the tight junctions is 
poorly understood. Over expression of occludin resulted in a decrease in transepithelial 
conductance, but surprisingly there was an increase in paracellular permeability as determined 
using mannitol, which is a hydrophilic molecule that can only permeate the paracellular route 
(Balda et al., 1996). Furthermore, occludin knockdown did not prevent the formation of 
functional tight junctions or affect gte but affected the kind of claudins that were expressed 
(Cereijido & Anderson, 2001). Although evidence indicates that occludin contributes to the 
regulation of paracellular permeation, its fundamental role is not yet defined. 
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Junction adhesion molecules (JAMs): JAM-1 or JAM-A is one of four JAMs identified so far. 
JAM-1 is a 42 kDa glycoprotein that belongs to the large immunoglobulin family. It has one 
transmembrane domain and two IgG-like folds in the extracellular domain (Fig 1.8; 
Schneeberger & Lynch, 2004)  JAM-1 has PDZ binding sites in its cytosolic tail and interacts 
with the PDZ domain of ZO-1, MUPP-1 and several other membrane associated guanylate 
kinase (MAGUK) proteins (Schneeberger & Lynch, 2004). JAM-1 plays a role in maintaining 
cell morphology and are involved in the assembly of junctional proteins and polarization of 
epithelia.  
 
 
 
 
 
 
 
 
Figure 1.8: Membrane topology of JAM-1. 
JAM-1 has two IgG folds in the extracellular domain. (Figure adapted from Schneeberger & 
Lynch, 2004). 
 
 
Claudins: Twenty four isoforms of claudin have been identified thus far. Claudins-1 and 2 were 
identified first as ~22 kDa bands from chicken liver fraction that was enriched with junctional 
proteins (Furuse et al., 1998). Claudin isoforms are now attributed to be the predominant proteins 
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in the anastamosing strands in freeze fractures replicas (see Fig. 1.5) (Cereijido & Anderson, 
2001). The sequence of claudin-1 and 2 derived from chicken liver extract suggested that they 
were transmembrane proteins with 4 membrane spanning regions (Furuse et al., 1998). The 
predicted membrane topology of claudins (Fig. 1.9) includes 2 extracellular loops of which one 
loop is larger. The loops of several claudins have charged residues and these extracellular loops 
vary greatly in net charge. Hence each loop has a distinct isoelectric point (Turksen & Troy, 
2004).  
 
 
Figure 1.9: Membrane topology of claudins. 
The distribution of signature residue motifs (WWCC) and charged residues depicted in the first 
extracellular loop is distinct for each claudin isoform. The COOH terminus has a conserved PDZ 
binding motif as shown. (Figure modified from Van Itallie & Anderson, 2004). 
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The claudins are speculated to form ion selective pores in the tight junction and also implicated 
in size selectivity, thus regulating paracellular permeability (Fig. 1.10; Turksen & Troy, 2004). 
The replacement of a basic residue in the extracellular loop of claudin-4 decreased paracellular 
permeability for Na+ versus Cl- without affecting the permeation of uncharged molecules through 
the paracellular route whereas replacing the acidic residues in the extracellular loop of claudin-
15 shifted the permeability ratio to favor Cl- instead of Na+ (Colegio et al., 2002). These results 
suggest that claudins might form channels that confer ion selectivity to the paracellular route as 
depicted in Fig. 1.10 and expression of specific combination of claudins might be the basis for 
differences in gte in different epithelia. MDCK I cells, which were considered to be “tight” 
epithelia as indicated by a very low gte, when transfected with claudin-2 that is usually lacking in 
this epithelia became “leaky” (Furuse et al., 2001), which again suggested that the gte in this 
epithelial model might be influenced by the type of claudins that are expressed.  
The cytosolic portion of claudins is mostly conserved with the exception of a portion of the 
cytoplasmic C-terminal tail, which shows significant divergence among different claudin 
isoforms. There is a YV sequence at the COOH-terminus of most claudins that is the site of 
interaction with the PDZ domains of ZO-1, 2 and 3 that link the claudins to the cytoskeleton 
(Itoh et al., 1999). The cytoplasmic tail reportedly is observed to be necessary for proper 
targeting of claudins to the apical cell junctions (Turksen & Troy, 2004).  
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Figure 1.10: Claudins are speculated to form ion channels in the paracellular space. 
The left panel is an idealized cross-sectional view of the tight junctions. Claudin strands are 
predicted to polymerize and form homo-and hetero-dimers along the junctional space in such a 
way as to form pores as depicted in the middle panel. The right panel is a representation of 
claudins forming ion selective pores at the tight junctions. The figure also shows the association 
of claudins with the plaque proteins ZO-1, ZO-2 and ZO-3 and also another plaque protein 
MUPP-1. The plaque proteins associate with actin as shown in the figure. (Figure adapted from 
Van Itallie & Anderson, 2004). 
 
Claudins are differentially expressed in various epithelia and endothelia. Claudin-5 has been 
observed only in the endothelium. Clauidin-11 is restricted to the myelin sheath of 
oligodendrocytes. Claudin-16 is exclusively expressed in the thick ascending limb of the loop of 
Henle, the distal tubules and collecting duct in the kidneys. The genetic disease familial 
hypomagnesemia with hypercalcuria is associated with mutations in claudin-16 and 
characterized by defective re-absorption of Mg2+ and Ca2+. Claudin-14 is expressed only in the 
organ of corti in the inner ear (Turksen & Troy, 2004). Most epithelia express more than one 
isoform of claudin. Based on experiments where L cells were transfected with more than one 
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kind of claudin, it has been proposed that the tight junctions constitute linear co-polymers of 
occludin and claudins. Claudins from adjacent cells show both homophilic and heterophilic 
interactions (Furuse, Sasaki & Tsukita, 1999). 
 
Plaque proteins: Plaque proteins are adaptors for cytosolic proteins involved in cell signaling 
and also form complexes with other cytosolic proteins in order to establish apical-basolateral 
polarity and bring about tight junction assembly (Furuse et al., 1994; McNeil, Capaldo & 
Macara, 2006).  Among all the plaque proteins mentioned above, the most prominent and first to 
be identified is ZO-1. ZO-1 and the related plaque proteins, ZO-2 and ZO-3 have significant 
interactions with most junctional proteins (Paris et al., 2007; Schneeberger & Lynch, 2004).  
ZO-1: ZO-1 is a 225 kDa plaque protein that belongs to the MAGUK protein family (Fanning et 
al., 1998). The N-terminal half of ZO-1 is homologous to other MAGUKS and has 3 PDZ 
domains, an SH3 domain, and an inactive GUK domain as shown in Fig. 1.11 (Funke, Dakoji & 
Bredt, 2005). The C-terminal half has a unique proline rich region (Fanning et al., 1998; 
Fanning, Ma & Anderson, 2002). Splice variants of ZO-1 may be differentially distributed in 
epithelial and endothelial tissue (Mitic & Anderson, 1998; Schneeberger & Lynch, 2004). ZO-1 
is as a scaffold protein that has several protein-protein interaction domains. The PDZ domains of 
ZO-1 interact with several junctional proteins including ZO-2, claudins and JAM-1 (Funke et al., 
2005). The GUK domain and the adjacent region rich in acidic residues associates with the C-
terminus of occludin (Li et al., 2005). ZO-1 also interacts with actin through its proline rich 
region (Fanning et al., 1998; Fanning et al., 2002). ZO-1 also associates with several actin 
binding proteins (Schneeberger & Lynch, 2004) 
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Figure 1.11: A modular representation of the various protein domains in ZO-1, ZO-2 and 
ZO-3. 
These domains are sites of protein-protein interactions and below each individual figure are 
indicated the proteins that bind these domains. (Adapted from Tsukita, Furuse & Itoh, 2001) 
 
 
ZO-2 and ZO-3: ZO-2 is a 160 kDa protein that has ~51% homology with ZO-1 and also binds 
several tight junction proteins, adheren junction proteins and actin. ZO-3 is a 130 kDa and is 
least similar of the three ZO proteins (Funke et al., 2005). All three proteins share the PDZ, SH3 
and GUK domains that are characteristic of most MAGUKS (Fig. 1.11; Schneeberger & Lynch, 
2004; Tsukita, Furuse & Itoh, 2001). 
Adheren junctions: Adheren junctions are formed primarily by the interactions of cadherin 
and catenin families of proteins. The cadherin that is present in epithelial cells is called E-
cadherin (epithelial cadherin). The cadherin and interacting catenins along with several 
regulatory molecules play a significant role to maintain cell adhesions. The adheren junction 
molecules regulate cytoskeletal rearrangements necessary for cell turnover and cell migration in 
cases such as wound healing (Gumbiner, 2005). 
E-cadherin belongs to the superfamily of cadherin proteins and specifically to the sub family of 
classical cadherins (Cavallaro & Christofori, 2004; Gumbiner, 2005; Hartsock & Nelson, 2007). 
E-cadherin is a glycoprotein with a single transmembrane domain. It has 5 extracellular repeat 
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domains (EC-1-5; Fig. 1.12) that are stabilized by Ca2+ (Gumbiner, 2005). This region is 
followed by the transmembrane domain (TM). The juxtamembrane domain (JMD) and the 
cytoplasmic catenin binding domain (CMD) are the two catenin binding domains. E-cadherin is 
organized as dimers at the adheren junction and form homophilic interactions with the cadherins 
of adjacent cells. The CBD interacts with β-catenin and the JMD interacts with the p120 catenin 
and the E-3 ubiquitin ligase, Hakai (Fig. 1.12; Cavallaro & Christofori, 2004; Hartsock & 
Nelson, 2007). 
 
 
 
 
Figure 1.12: Modular representation of the domains in E-cadherin and interacting 
molecules. 
The extracellular domains (EC), is followed by the transmembrane domain (TM) and the 
cytosolic domains include the juxtamembrane domain (JMD) and the catenin binding domain 
(CBD). (Figure modified from Hartsock & Nelson, 2007). 
 
 
Catenins are involved in connecting cadherins to the cytoskeleton (Gumbiner, 2005). β-catenin is 
an armadillo repeat protein. The protein is so described, after the same domain found in the 
drosophila protein armadillo. The armadillo repeats are 40 residue sequences that assemble as 
helices and are present in signalling molecules. The core of the protein is made of helices of 
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armadillo repeat sequences that are assembled into a superhelix. This superhelix has a positively 
charged groove that is involved in interactions with several proteins and also subject to 
regulation by several kinases (Daugherty & Gottardi, 2007). β-catenin binds α-catenin, which in 
turn associates with actin and thus serves to link E-cadherin to the cytoskeleton (Daugherty & 
Gottardi, 2007). The other major catenin that associates with E-cadherin is the p120 catenin.  
 
 
 
Figure 1.13: Interaction of E-cadherin, catenins and actin. 
E-cadherin forms homodimers that associate with the homodimers of adjacent cells through the 
extracellular domains. The α, β and p120 catenins associate directly or indirectly with E-cadherin 
and actin. (Figure was modified from Cavallaro & Christofori, 2004). 
 
 
The interaction between E-cadherin and β-catenin is subject to regulation by several kinases. The 
serine phosphorylation of E-cadherin by glycogen synthase kinase 3β (GSK3β) and casein kinase 
2 (CK2) increases the affinity of interaction with β-catenin by several fold whereas serine 
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phosphorylation by CK1 decreases the affinity (Daugherty & Gottardi, 2007). Tyrosine 
phosphorylation of both E-cadherin and β-catenin decreases the affinity of interaction between 
the two proteins (Daugherty & Gottardi, 2007). The interaction of β-catenin with E-cadherin is 
necessary to prevent E-cadherin from being degraded (Daugherty & Gottardi, 2007). It has been 
shown that tyrosine phosphorylation targets E-cadherin for rapid degradation. The E-3 ligase, 
Hakai (Fig. 1.12), has been implicated in the proteosomal degradation of E-cadherin (Fujita et 
al., 2002). 
GSK3β and CK1 are also involved in regulation of β-catenin. Phosphorylation by these kinases 
targets β-catenin for proteosomal degradation (Daugherty & Gottardi, 2007). However, 
activation of a serine-threonine phosphatase, PP1 by wnt signalling prevents degradation of β-
catenin (Cavallaro & Christofori, 2004; Daugherty & Gottardi, 2007). Activation of this cascade 
by wnt increases cytosolic β-catenin protein levels, which then enters the nucleus where it 
activates several transcription factors. Hence β-catenin is involved in cell proliferation and also 
tumorogenesis (Daugherty & Gottardi, 2007). 
The GTPases, Rho and Rac, of the small G protein family that are involved in regulating F-actin 
organization are also involved in the localization of E-cadherin to the adheren junctions. 
Inhibition of Rac and Rho has been reported to decrease E-cadherin immunoreactivity (Braga et 
al., 1997). It is speculated that these GTPases act together to regulate localization of E-cadherin 
at the intercellular junctions. E-cadherin and β-catenin associate with ZO-1 and are observed to 
be early players in the assembly of tight junctions (Gumbiner, Stevenson & Grimaldi, 1988; 
Rajasekaran et al., 1996). Hence the functional roles of E-cadherin and β-catenin involve 
cytoskeletal rearrangements to mediate changes in cell shape and regulate cell migration, 
turnover and proliferation. They might also be necessary to promote tight junction assembly. 
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Actin cytoskeleton: Actin is a 42-45 kDa, abundant protein encoded by a gene family that is 
highly conserved. In humans, six genes code for actin. Four α actin isoforms are expressed 
predominantly in muscle cells and the β and γ actin isoforms are expressed in non-muscle cells. 
Actin exists in 2 physical forms in cellular cytoplasm, a monomeric globular form called G-actin 
and a polymeric filamentous form called F-actin. F-actin is formed by the polymerization of G-
actin (Lodish et al., 1995).  
Actin filaments are distributed throughout the cell and are an integral component of the cell 
cytoskeleton. Most of the F-actin in the cell exists in the form of microfilaments. Microfilaments 
are short actin filaments that associate with certain actin binding proteins that help associate 
microfilaments into specific structures. Microfilaments are arranged as bundles or networks 
based on localization and function. Bundles are formed by the parallel arrangement of 
microfilaments that are stabilized and connected to each other through short cross-linking 
proteins. Networks are formed by the association of microfilaments with long cross-linking 
proteins. In epithelial cells, the microfilaments are present in microvilli, the cortex, and in stress 
fibers. Microvilli are found along the apical surface of the cells and have longitudinal bundles of 
microfilaments. The cortex is a region just below the plasma membrane. The cortical actin 
cytoskeleton is a dense network of microfilaments (Lodish et al., 1995). Stress fibers are formed 
by bundles of microfilaments and are present either at the leading edges of migrating cells or 
lying at the basal portion of adherent cells (Lodish et al., 1995). The apical junctional complexes, 
the tight junctions and adheren junctions, associate with actin filaments that circumscribe the 
cell. These actin filaments associate with myosin II and form the perijunctional actomyosin II 
complex (Lodish et al., 1995). The perijunctional actomyosin ring circumscribes the cell at the 
region of the zonula adherens (Lodish et al., 1995). 
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Polymerization of actin: G-actin has a cleft in the middle that separates its two lobes and in this 
cleft is an ATP binding site. Both G and F-actin are associated with ATP or ADP. The ATP 
bound monomers of G-actin polymerize and after polymerization, the ATP is hydrolyzed to 
ADP. Thus, most of the F-actin consists of ADP-G-actin monomers. The process of 
polymerization depicted in Fig. 1.14, does not necessarily require ATP hydrolysis although the 
rate of polymerization is greater in the presence of ATP. The ATP bound cleft is called the (+) 
end and the other end of the monomer is the (-) end. G-actin monomers add on to the growing 
filament, preferably towards the + end and hence the filament grows more rapidly from its (+) 
end than the (-) end (Lodish et al., 1995). The polymerization is reversible. G and F-actin exist in 
equilibrium at a certain critical concentration (Lodish et al., 1995).   
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Polymerization of actin. 
Figure modified from www.cytochemistry.net (Childs, 2001). 
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Compounds that disrupt the equilibrium between G-actin and F-actin can increase the rate of 
depolymerization of F-actin. Cytochalasin is a compound that binds to the (+) end of F-actin and 
prevents the addition of G-actin monomers. Latrunculin A is a toxin secreted by sponges that 
binds to G-actin and prevents polymerization. Phalloidin, a toxin derived from the mushroom 
Amantia phalloides, binds F-actin such that F-actin cannot depolymerize (Lodish et al., 1995). 
Based on this property, phalloidin linked to fluorescent dyes is commonly used to visualize actin 
in cells. 
In non-migrating cells, the network of actin is responsible for maintaining the cytoplasm in a gel 
like state. In migrating cells, the cytoplasm is in a solution state allowing for easy movement of 
the cell. The transition between the “gel” and “sol” state is mediated by the proteins gelsolin and 
clofilin. These proteins are actin severing proteins that break actin filaments into smaller 
fragments and prevent re-polymerization by remaining bound to the (+) end of the fragments 
(Lodish et al., 1995).  
Signalling pathways regulate the tight and adheren junctions:  The family of small 
GTP proteins that include Rho, Rac and Cdc42 are modulators of the actin cytoskeleton. These 
proteins play a significant role in actin-based activities such as cell migration and cytoskeletal 
rearrangements. Rearrangements of the cytoskeletal proteins, especially actin, are increasingly 
associated with regulation of epithelial and endothelial junctional proteins (Bruewer et al., 2004; 
Jou, Schneeberger & Nelson, 1998). Both constitutively active and dominant negative mutants of 
Rho, Rac and Cdc42 cause reorganization of F-actin and either induction or loss of stress fibers 
(Bruewer et al., 2004). Toxins from Clostridium species that ADP-ribosylate or glucosylate Rho 
reduce Rho GTPase activity and hence cause depolymerization of actin filaments (Bruewer et al., 
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2004; Hecht et al., 1992; Moore et al., 1990). Changes in the activity of these GTPases, in most 
cases, result in an increase in gte and paracellular permeability associated with a disruption of 
junctional proteins (Bruewer et al., 2004). Rho family proteins, particularly Rho A, play a 
significant role in modulating actin organization (Fig. 1.15). Rho affects actin organization 
through Rho kinase (also known as ROCK), which can cause a direct or indirect phosphorylation 
of myosin light chain (MLC) (Riento & Ridley, 2003). Decreased Rho activity is associated with 
a decrease in phosphorylation status of MLC. Both phosphorylation and dephosphorylation of 
MLC alter actin organization (Riento & Ridley, 2003; Turner et al., 1997). Activation of myosin 
light chain kinase (MLCK) causes an increase in MLC phosphorylation, gte and paracellular 
permeability, primarily by a reorganization of actin cytoskeleton (Clayburgh et al., 2004). 
Physiological events such as increased sodium glucose uptake through SGLT-1 (Turner et al., 
1997), hyperosmotic stress and hyperpolarization enhance gte and paracellular permeability by 
increasing MLC phosphorylation (Di Ciano-Oliveira et al., 2003; Szaszi et al., 2005). Hence 
MLCK activity and RhoA/ROCK activity are associated with increased ppMLC (dual 
phosphorylated myosin light chain). However it must be noted that events that are associated 
with MLC dephosphorylation such as ATP depletion and benzylkonium chloride exposure (a 
surfactant used to enhance corneal permeability) also cause a reorganization of actin and 
increased permeability involving a loss in localization of one or more junctional proteins 
(Bacallao et al., 1994; Guo et al., 2007; Mandel, Doctor & Bacallao, 1994). Disruption of actin is 
often associated with changes in junction protein organization and paracellular permeability. 
Moreover the junctional proteins associate directly or indirectly with the perijunctional actin 
ring. Hence it is proposed that changes in contractility of the perijunctional actomyosin ring 
might regulate paracellular permeability (Madara, 1998). 
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Figure 1.15: Regulation of F-actin organization by the Rho signaling pathway. 
Tight junction proteins are phosphorylated or dephosphorylated by several serine threonine and 
tyrosine kinases or phosphatases that can either cause redistribution of these proteins away from 
the cell-cell contact regions or promote assembly of the junction. Several protein kinase C (PKC) 
isoforms are involved in regulation of the junctional proteins. The role of PKC in modulating the 
junctional proteins varies based on cell type and isoform as shown in Fig. (1.16).  
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Figure 1.16: PKC isoenzymes in various cell types and their role in regulation of tight 
junction assembly. 
(figure modified from Gonzalez-Mariscal, Tapia & Chamorro, 2007) 
 
Oxidative stress, extracellular and intracellular Ca2+ and toxins such as zona occludens toxin 
(ZOT) and toxin A from Clostridium difficle are among the triggers for the activation of a PKC 
isoform that mediates reorganization of the actin cytoskeleton and also causes the disruption of 
tight junction proteins. Several other serine threonine kinases (e.g. MAPK) and phosphatases 
(PP1a and PP2), receptor and non receptor tyrosine kinases such as c-src, WNK-4 and c-yes also 
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influence tight junction permeability by phosphorylation or dephosphorylation of occludin, ZO-1 
and claudins (Gonzalez-Mariscal, Tapia & Chamorro, 2007). 
Extracellular molecules that modulate paracellular permeability: 
The multimolecular complex that regulates paracellular permeability is a target for several 
extracellular molecules that modulate barrier function. These include molecules that mediate 
physiological events, toxins that have pathological effects and therapeutic molecules that are 
designed to enhance paracellular permeability. Several bacterial and fungal toxins disrupt 
epithelial barriers. A few examples include the enterotoxin produced by Clostridium perifringens 
and the fungal toxin, Ochratoxin A, which cause degradation of claudin-4 (Schneeberger & 
Lynch, 2004), (McLaughlin et al., 2004). ZOT (zona occludens toxin), which is derived from 
Vibrio cholerae, induces time-and dose-dependent rearrangement of F-actin, possibly through a 
PKCα dependent mechanism (Fasano et al., 1995). Clostridium difficile toxins A and B disrupt 
GTPase activity of Rho family proteins by UDP-glucosylation (Richard et al., 1999). They 
increase paracellular permeability by causing the disorganization of apical and basal F-actin and 
eventually ZO-1, 2 and occludin. Bactrioides fragilis toxin (BFT) is a metalloprotease that 
cleaves E-cadherin and also causes a reorganization of F-actin (Richard et al., 1999; Wu et al., 
1998; Wu et al., 2007; Wu et al., 2006), thereby changing cell morphology and increasing barrier 
function.  
Several charged molecules such as protamines, chitosans and polylysines also increase gte and 
paracellular permeability. Protamine is an arginine rich polycationic peptide that affects barrier 
integrity of epithelial monolayers (Peterson & Gruenhaupt, 1992). Confocal images of MDCK I 
cells exposed to protamine showed condensation of the F-actin microfilaments and reduced 
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occludin immunoreactivity in  a concentration dependent manner (Peixoto & Collares-Buzato, 
2005). 
Therapeutic modulation of paracellular permeability:  
There is a strong link between permeability of solutes across the paracellular route and the 
arrangement of actin and various junctional proteins. Moreover several signalling pathways are 
involved in modulating the localization and organization of these proteins. Molecules that can 
disrupt this fine equilibrium and induce transient changes in permeability are useful in opening 
the paracellular pathway to solutes and provide a means to deliver therapeutic molecules across 
these selective epithelial barriers. 
A variety of techniques is being investigated currently to selectively and transiently circumvent 
the barrier function of epithelia and endothelia. Methods are being developed to reduce epithelial 
tight junctions enough to allow large molecules to diffuse to the interstitial space. ZOT provides 
a naturally occurring alternative for increasing the permeability of small intestine epithelia 
(Fasano et al., 1997). ZOT and its eukaryotic homologue, zonulin, interact with an epithelial 
membrane receptor that leads to a reduction in epithelial resistance, presumably by activation of 
PKCα (Fasano, 2000; Fasano et al., 1995). The effects of ZOT are rapid in onset (< 20 minutes) 
and readily reversible on washout (Fasano, 2000). Thus ZOT is an excellent candidate as an 
adjunct to standard therapy to increase oral bioavailability of large molecules (Fasano & Uzzau, 
1997). In fact, ZOT has been used to increase the permeation of anticonvulsant drugs across 
epithelial monolayers (Karyekar et al., 2003), to increases the uptake of PEG 4000 from rabbit 
small intestine (Salama et al., 2003), and increase intestinal permeability to insulin and 
immunoglobulins (Fasano & Uzzau, 1997). In diabetic rats, the bioavailability of oral insulin was 
sufficient to control blood glucose to the same degree as parenteral administration when co-
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adminstered with ZOT (Fasano & Uzzau, 1997). However, ZOT has some drawbacks as a more 
generalized therapeutic in that it is a large peptide (399 A.A.) and its effects are observed only in 
the small intestine where distinct receptors are present (Uzzau et al., 2001). Small peptides 
derived from ZOT (e.g. AT1002, a six residue peptide) have shown promise in enhancing drug 
delivery (Song, Fasano & Eddington, 2007a; Song, Fasano & Eddington, 2007b).  
Peptides corresponding to the first and second extracellular loops of occludin have been tested as 
tight junction modulators. The earliest occludin peptides synthesized were ~ 44 amino acid 
sequences that had a sequence based on that of the first and second extracellular domains of 
chick occludin. The peptides were tested on A6 cells (derived from Xenopus) and the peptide 
corresponding to the second extracellular loop resulted in a five fold increase in the gte after 5 
days of exposure. The peptide allowed for permeation of large dextrans (up to 40 kDa) after 36 
hours of exposure and the effect of the peptide was reversible (Wong & Gumbiner, 1997). The 
second set of peptides studied also had sequences based on chick occludin extracellular loops. 
These peptides increased gte in minutes (Lacaz-Vieira et al., 1999). Synthetic peptides, based on 
the sequence of the second extracellular loop of rat occludin tested on the rat sertoli cells resulted 
in an increase in gte after 4 to 5 days (Chung et al., 2001). Peptides based on the sequence of the 
first and second extracellular loops of human occludin were tested on the Caco-2 cells, which are 
derived from human colon. A 24 amino acid peptide corresponding to the first extracellular loop 
was effective in increasing gte and allowed for permeability of small molecules such as mannitol. 
The peptides were effective from the basolateral side and took more than six hours to increase 
paracellular permeability significantly (Tavelin et al., 2003). In order to have effect from the 
apical side, occludin peptides modified by the addition of chemical groups such as lipoamino 
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acid have been designed and are showing promise in increasing permeability (Everett et al., 
2006; Tavelin et al., 2003). 
Channel forming peptides and modulation of paracellular permeability: 
A series of channel forming peptides have been synthesized in this laboratory with the ultimate 
goal of generating a compound that can enhance apical Cl- conductance and serve as a substitute 
for endogenous Cl- channels that are defective in diseases such as cystic fibrosis. M2GlyR is a 23 
residue peptide based on the sequence of the second transmembrane segment M2 of the glycine 
receptor (GlyR), which is a Cl- selective channel (Reddy et al., 1993). M2GlyR increased Cl- 
conductance across lipid bilayers with single channel conductance matching that of the glycine 
receptor (Reddy et al., 1993). However, the aqueous solubility of this peptide was poor and 
proved to be a limitation to test the peptide in epithelial monolayers. Solubility was enhanced by 
the addition of four lysine residues at the C-terminus of M2GlyR generating the peptide CK4-
M2GlyR (PARVGLGITTVLTMTTGSSGSRAKKKK; Tomich et al., 1998; Wallace et al., 
1997). CK4-M2GlyR increased anion secretion across epithelial monolayers and the secretion 
was inhibited by a Cl- channel blocker, diphenylamine-2-carboxylate (Wallace et al., 1997). The 
addition of four lysines at the N-terminus of M2GlyR to generate NK4-M2GlyR 
(KKKKPARVGLGITTVLTMTTGSSGSRA) resulted in a peptide that elicited an indicator of 
short circuit current (Isc), an indicator of anion secretion or cation absorption that was 50% 
greater than its CK4 counterpart (Broughman et al., 2001). Further studies revealed that in the 
lysine residues at the C-terminus (CK4) masked a nucleation site by forming a capping structure 
and limited the oligomerization of this peptide (Broughman et al., 2002a) an effect not observed 
with the amino lysine residues (NK4). These results suggested that the C-terminal portion of the 
peptide was involved in aggregation. Furthermore the removal of C-terminus residues resulted in 
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a decrease in aggregation and removal of 11 residues from the C-terminus virtually eliminated 
aggregation (Broughman et al., 2002b). The effect of the truncated peptide on Isc remained 
unaltered until the removal of 5 residues from the C-terminus and Isc progressively decreased 
with subsequent removal of C-terminus residues (Broughman et al., 2002b). Taken together the 
results suggested that the C-terminus was responsible for aggregation and that only the N-
terminus residues might be necessary to form ion channels. Hence, a peptide that has a sequence 
based on the N-terminal half of NK4-M2 GlyR was designed. The peptide is palindromic around 
the central leucine. The final sequence, KKKKAARVGLGITTVLVTTIGLGVRAA was named 
NC-1059 (Broughman et al., 2002b). 
NC-1059 increased anion secretion and gte across MDCK monolayers in a concentration 
dependent manner (Broughman et al., 2004). NC-1059 induced increase in gte reached a peak 
value and remained elevated even after the Isc declined (Broughman et al., 2004). This suggested 
that in addition to an increase in transcellular conductance, NC-1059 also increased paracellular 
conductance. Dextran molecules can only permeate the paracellular route. Hence various sizes of 
dextran were used to determine whether the permeation through the paracellular route was 
enhanced by NC-1059 and also to establish the size selectivity of the enhanced paracellular flux. 
NC-1059 enhanced the permeation of molecules as large as 9.5 kDa but not 77 kDa (Broughman 
et al., 2004). This established that NC-1059 enhanced paracellular permeability in a size 
selective manner. The increase in gte was reversible and the monolayers returned to pretreatment 
gte and permeation within 48 hours (Broughman et al., 2004). These results demonstrated that 
NC-1059 is a compound that can reversibly alter the barrier function of epithelial monolayers 
and enhance paracellular permeation of hydrophilic molecules. Hence NC-1059 holds potential 
to be developed as a co-therapeutic to aid in drug delivery across epithelia. 
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The next two chapters build on observations regarding NC-1059 that has been presented above. 
Experiments were conducted to determine if the effects of NC-1059 can be generalized to 
epithelia derived from a variety of tissue sources and the underlying molecular changes that 
accompany the effects on paracellular permeability. Experiments detailed in chapter 2 were 
designed to determine whether the permeability enhancing effects of NC-1059 can be 
generalized to epithelial cell models that are derived from other sources. Chapter 3 focuses on 
molecular mechanisms that account for the changes in paracellular permeability that were 
reported. Particular attention was paid to the location and abundance of actin and the junctional 
proteins ZO-1 and occludin. Chapter 4 provides a brief summary of the observations along with 
concluding remarks. 
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 Abstract: 
 NC-1059 is a synthetic channel-forming peptide that provides for ion transport across, and 
transiently reduces barrier integrity of, cultured epithelial monolayers derived from canine 
kidney (MDCK cells)(Broughman et al., 2004). Experiments were conducted to determine 
whether epithelial cells derived from other sources were similarly affected. Epithelial cells 
derived from human intestine (T-84), airway (Calu-3), porcine intestine (IPEC-J2) and 
reproductive duct (PVD9902) were grown on permeable supports. Basal short circuit current (Isc) 
was typically less than 3 μA cm-2 for most epithelia. Apical NC-1059 exposure caused, in all cell 
types, an increase in Isc to >15 μA cm-2, indicative of net anion secretion or cation absorption that 
was followed by an increase in transepithelial conductance (in mS cm-2; T-84, 1.6 to 62; 
PVD9902, 0.2 to 51; IPEC-J2, 0.3 to 26; Calu-3, 2.2 to 13). These results are consistent with the 
peptide affecting transcellular ion movement with a likely effect also on the paracellular route. 
NC-1059 exposure increased dextran permeation when compared to basal permeation, which 
documents an effect on the paracellular pathway. In order to evaluate membrane ion channels, 
experiments were conducted to study the dose dependence and stability of the NC-1059-induced 
membrane conductance in Xenopus laevis oocytes. NC-1059 induced a dose dependent increase 
in oocyte membrane conductance that remained stable for greater than 2 hours. The results 
demonstrate that NC-1059 increases transcellular conductance and paracellular permeation in a 
wide range of epithelia. These effects might be exploited to promote drug delivery across barrier 
epithelia.  
Key words: Transepithelial conductance, Short circuit current, Dextran Permeability, MDCK, 
PVD9902, IPEC-J2, Calu-3. 
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Introduction: 
NK4-M2GlyR (KKKKPARVGLGITTVLTMTTGSSGSRA) is a synthetic channel forming 
peptide whose sequence is based on the second transmembrane segment (M2) of the glycine 
receptor (GlyR) alpha-subunit (Broughman et al., 2001; Tomich et al., 1998; Wallace et al., 
1997). Lysine residues were added to the N-terminus of M2GlyR to increase aqueous solubility. 
It was shown subsequently that sequential removal of C-terminus residues from NK4-M2GlyR 
reduced aggregation of the peptide in solution and peptides truncated up to five residues from the 
C-terminus retained ion transport properties (Broughman et al., 2002b). Hence a palindromic 
peptide consisting of the 11 N-terminal residues from M2GlyR followed by a central leucine and 
then an inverse sequence of the N-terminal segment, was synthesized to maximize channel-
forming activity (Broughman et al., 2002b). Proline residues were replaced with alanines to 
improve the chemical synthesis to arrive at the final sequence 
KKKKAARVGLGITTVLVTTIGLGVRAA, which was named NC-1059. 
Apical exposure of MDCK cell monolayers to NC-1059 caused a concentration dependent 
increase in short circuit current (Isc) (Broughman et al., 2004), a measure of net ion transport. 
Furthermore, the apparent dissociation constant, kapp, was reported to be 50 µM, which is four 
fold lower than the originally designed NK4-M2GlyR. In these studies, transepithelial electrical 
conductance (gte) began to increase with Isc and continued to increase even after Isc reached peak 
value and began to decline. Exposure of MDCK cell monolayers to NC-1059 also increased 
permeation of 9.5 kDa fluorescein isothiocynate (FITC)-conjugated dextran suggesting that a 
paracellular route was opened by NC-1059 (Broughman et al., 2004). gte returned to pretreatment 
values within 2 days after NC-1059 exposure, the shortest time point tested (Broughman et al., 
2004). These observations were very encouraging, as there is a tremendous impetus to identify 
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molecules that may serve as “absorption enhancers” to augment delivery of hydrophilic and large 
uncharged therapeutics across epithelial barriers (Kondoh & Yagi, 2007). 
Tight junctions are multimolecular complexes between apical intercellular regions of epithelial 
cells that regulate paracellular permeability. Several techniques are being investigated to 
selectively and transiently reduce barrier function of epithelia or endothelia to allow the diffusion 
of therapeutic molecules to the interstitial space. Calcium chelators and surfactants disrupt 
barrier integrity but have unacceptable side effects including changes in cell function and 
diminished cell adhesion (Thompson, Cavitt & Audus, 1994). Peptides corresponding to first and 
second extracellular loops of occludin, a tight junction protein, increased paracellular 
permeability, but required several hours to show significant effects (Chung et al., 2001; Lacaz-
Vieira et al., 1999; Tavelin et al., 2003; Wong & Gumbiner, 1997). More recently, a modified 
occludin peptide was shown to be effective at high concentrations (1 mM) in enhancing 
permeability across airway epithelia (Everett et al., 2006). The zonula occludens toxin of Vibrio 
cholerae (ZOT) provides a natural alternative to increase the permeability of small intestine 
epithelia (Fasano & Uzzau, 1997). ZOT has a rapid onset (< 20 minutes) and is reversible. Yet, 
ZOT has drawbacks as a more generalized co-therapeutic agent in that it is a large peptide (399 
amino acids) dependent on the presence of a membrane receptor that may not be present in all 
epithelia (Fasano et al., 1995).  
NC-1059 has the potential to be developed into a co-therapeutic that can increase bioavailability 
of various drugs. NC-1059 is a small peptide that can be readily synthesized. Additionally, we 
hypothesize that NC-1059 can modulate barrier function of epithelia derived from varied 
sources. The goal of the study presented in this paper is to determine the effect of NC-1059 on 
epithelial cell lines derived from a variety of tissues. This study evaluates the differences in Isc 
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response, changes in gte and paracellular permeation between different epithelia when exposed to 
various concentrations of NC-1059. Additionally, studies were conducted using Xenopus laevis 
oocytes to isolate and characterize effects of NC-1059 on membrane conductance independent of 
effects on cell-cell interactions. 
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Methods: 
Peptide Synthesis: NC-1059 was synthesized by solid phase peptide synthesis using 9-
fluorenylmethoxycarbonyl chemistries and purified as described previously (Broughman et al., 
2002a).  
Chemicals and stock solutions: 1-ethyl-2-benzimidazolinone (1-EBIO) was purchased from 
Acros (Fisher Scientific, Pittsburgh, PA). Unless specified otherwise, all other chemicals used 
were purchased from Sigma Aldrich (St. Louis, MO). NC-1059 was prepared as a 5 mM stock in 
deionized water immediately before addition to the experimental chamber. 
Cell Culture: T-84 Cells were obtained from Dr. Daniel Devor (University of Pittsburgh, 
Pittsburgh, PA) and maintained in culture as described previously (Broughman et al., 2004; 
Broughman et al., 2001). Cells were grown on 25 cm2 flasks (Corning Incorporated, Corning, 
NY) with a medium containing a 1:1 mixture of Dulbecco’s modified Eagle medium (DMEM) 
and Nutrient F12 (Gibco, Invitrogen, Carlsbad, CA), 5% heat inactivated fetal bovine serum 
(FBS; Atlanta Biologicals, Atlanta, GA) and 1% penicillin and streptomycin (Gibco). 
Approximately 5*105 cells were seeded onto 1.13 cm2 permeable supports (Snapwell, Costar, 
Corning Incorporated). The medium was refreshed every other day until used for 
experimentation with the last medium change occurring one day prior to analysis. All other cell 
types were maintained using similar techniques, with some exceptions noted below.  
IPEC-J2 cells were provided by Dr. Anthony Blikslager (North Carolina State University, 
Raleigh, NC) and were grown in a medium containing 1:1 mixture of DMEM and Nutrient F12, 
5% heat inactivated FBS, 1% insulin-transferrin-selenium and 1% penicillin and streptomycin. 
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PVD9902 (Carlin et al., 2006) cells were grown in a medium containing DMEM, 10% heat 
inactivated FBS, and 1% penicillin and streptomycin. The PVD9902, IPEC-J2 and T-84 cells 
were grown on the permeable supports, typically for 14 days prior to experimental evaluation.  
Calu-3 cells were grown with a medium containing a 1:1 mixture of DMEM and Nutrient F12, 
15% heat inactivated FBS, 2 mM glutamine and 1% penicillin and streptomycin. Cells were 
grown on the permeable supports for 28-34 days. The apical medium was removed on the second 
day and cells were cultured without medium on the apical surface thereafter until evaluation.                                
Electrical Measurements: Isc and transepithelial electrical potential were measured using a 
modified Ussing chamber (model DCV9, Navicyte, San Diego, CA) as described previously 
(Broughman et al., 2004; Broughman et al., 2001). Monolayers were bathed symmetrically with 
Ringer solution (in mM: 120 NaCl, 25 NaHCO3, 3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, and 1.2 
CaCl2) that was prepared fresh daily, maintained at 37ºC, and bubbled with  5% CO2 / 95% O2 to 
maintain pH and to provide mixing. Monolayers were clamped to 0 mV using a voltage clamp 
apparatus (model 558C-5, University of Iowa, Dept. of Bioengineering, Iowa City, IA). A 5 s 
bipolar pulse was applied every 100 s to allow for gte assessment. Data acquisition was 
performed at 1 Hz with an Intel based computer using Aqknowledge software (v. 3.2.6, BIOPAC 
Systems, Santa Barbara, CA) and MP100A-CE interface. The current measured in response to 
the voltage pulse was used to calculate gte using Ohms law, gte = ∆I/∆V. 
Xenopus oocyte isolation: Oocytes were isolated as described previously (Broughman et al., 
2004) from human chorionic gonadotropin treated Xenopus laevis (Xenopus One, Ann Arbor, 
MI) that were housed individually at 17ºC. All procedures involving animals were conducted in 
compliance with American Physiological Society guidelines and the procedure were approved by 
the university IACUC. The follicular layer of the oocytes was removed using collagenase and 
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trypsin inhibitor in ND-96 that was nominally Ca2+ free (in mM: 96 NaCl, 1 KCl, 1 MgCl2, 5 
HEPES, pH=7.5). Oocytes were washed subsequently with nominally Ca2+ free ND-96 and 
incubated in a hypotonic solution (0.1 M K2HPO4 and 0.1% bovine serum albumin) for 1 hour 
with gentle rolling at 15 minute intervals. Oocytes were then maintained in modified Barth’s 
solution (in mM: 88 NaCl, 1 KCl, 0.3 Ca(NO3)2, 0.41 CaCl2, 0.82 MgSO4, 2.4 NaHCO3, 10 
HEPES, pH=7.5) containing penicillin and streptomycin at 17ºC until used. 
Membrane conductance measurements: Oocyte membrane conductance was measured as 
described previously (Broughman et al., 2004) using a two electrode voltage clamp technique. 
Recordings were conducted in ND-96 (in mM: 96 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2, 5 HEPES,). 
Briefly, the oocytes were impaled with glass pipettes having a Ag/AgCl electrode filled with 1 M 
KCl. The electrodes were connected to a voltage clamp amplifier (Gene Clamp 500B, Axon 
Instruments, Foster City, CA) and an analog to digital converter (DigiData 1200, Axon 
Instruments). The software used for data acquisition and analysis was pClamp 9.0 (Axon 
Instruments). Oocyte recordings were carried out using 2 voltage clamp protocols. In the first 
repeating ‘diary’ protocol, oocytes were sequentially held at -30 mV for 128 ms and then held at 
-90 mV, -30 mV, 0 mV, and 30 mV for a duration of 1000 ms each (total protocol duration = 
4.128 s). The protocol was repeated throughout the recording to assess the stability of the 
membrane conductance for the entire duration of the experiment. The second ‘step’ protocol was 
employed to determine with greater accuracy the slope conductance of the oocyte. The protocol 
included nine 2048 ms sweeps consisting of an initial 548 ms at -30 mV followed by 1000 ms at 
the step potential and ending with 500 ms at -30 mV. The step potential ranged from -100 mV to 
+60 mV at 20 mV increments. A mean current from the middle 250 ms of each step potential 
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was used to construct a current-voltage relationship (I-V plot). Data were fitted by a linear 
regression and slope conductance was obtained from the fit. 
The dose dependence of the NC-1059-induced changes in Xenopus laevis oocyte conductance 
was determined by making bolus additions of NC-1059 to a flowing bath. Doses of increasing 
size ranging from 1.25 to 20 nmoles of NC-1059 were added to the bath (~0.5 mL bath with 0.5 
mL/min flow rate). Each addition was made after the current reached a plateau following the 
previous exposure and the slope conductance had been determined using the protocol described 
above. To determine if the NC-1059-induced conductance remains stable for a long duration, 
oocytes were exposed to 5 nmoles of NC-1059 and, once the membrane conductance reached a 
stable value, the step protocol was conducted to determine the slope conductance. The step 
protocol was repeated periodically thereafter with the entire recording lasting 2 hours.  
Dextran permeability assay: Dextran permeation through the monolayer was measured as 
described previously (Broughman et al., 2004). Media were removed and the monolayers were 
washed with warm PBS. In untreated and NC-1059 exposed monolayers, Ringer solution was 
added to the basolateral (1 mL) and apical (200 μL) compartments in the Snapwell culture 
system. NC-1059 was added to the Ringer solution on the apical side of the monolayers to result 
in a final concentration of 200 μM NC-1059. Monolayers were also exposed symetrically to 5 
mM EDTA in hypotonic Ringer solution (diluted 1:1 with deionized H2O). FITC conjugated-
dextran (0.5 mg of 10, 20, 40 or 70 kDa) was added to the apical compartment of all treatments. 
After incubation at 37ºC for 1 hour, samples were taken from the basolateral compartment for 
determination of fluorescence intensity (Fluorskan Ascent FL, Labsystems). A series of dilutions 
of each size of dextran was prepared and fluorescence determined as a function of concentration. 
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A linear regression was used to derive the slope and to calculate the amount of dextran that 
permeated the monolayer.  
Data analysis: All results are reported as mean ± SEM. All graphs and regression fits were 
completed using Sigmaplot (v 6.0, SPSS Inc, Richmond, CA) or Excel (v 11.8, Microsoft Corp, 
Redmond, WA). The student’s t-test (Sigmaplot) and ANOVA (Excel) were used for statistical 
analysis where required. Concentration dependence was determined using the maximal Isc 
recorded following exposure to each concentration of NC-1059. Kinetic parameters for 
concentration dependence were determined by fitting the following modified Hill equation (Eqn. 
1) to each data set.  
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In the above equation Isc min is the basal Isc prior to peptide addition. ∆Isc max is the greatest 
increase in Isc observed during exposure to a given concentration of NC-1059. The apparent KD 
(kapp) is the concentration required to achieve half maximal Isc and b is the Hill coefficient. 
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The time course for NC-1059 induced changes in gte was determined by fitting with a sigmoidal 
function (Eqn. 2) to values of gte that were calculated every one hundred seconds throughout 
each experiment using the time of NC-1059 exposure as the starting point for data acquisition.  
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In Eqn. 2, gte min is the baseline conductance and Δgte max is the peak change in conductance 
reached during the recording for each concentration. b is inversely proportional to the slope at 
half Δgte max. The data used for the fit were restricted to ~300 s after the peak gte was reached. 
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Results: 
NC-1059 induces a change in electrical parameters for all epithelia that were tested. 
Experiments were conducted to determine if the concentration dependent changes observed in Isc 
and gte with MDCK cells exposed apically to NC-1059 can be generalized to epithelia derived 
from different tissues and species. Typical and summarized results for each cell type are 
presented in Figs. 1 - 4. 
T-84 cells derived from human colon: NC-1059 caused a concentration dependent increase in Isc 
and gte across T-84 cell monolayers. Fig. 1A shows the recording from a typical experiment in 
which an epithelial cell monolayer was exposed apically to NC-1059 (60 μM). An initial Isc of 2 
μA cm-2 was measured. The monolayer was exposed to 1-EBIO (300 μM) prior to peptide 
exposure as indicated by the solid bar. 1-EBIO activates Ca2+ sensitive K+ channels, IK and SK 
(Devor et al., 1996b), hyperpolarizing the cells and thus increasing the electrochemical driving 
force for anion secretion. 1-EBIO can also activate the cystic fibrosis transmembrane regulator 
(CFTR) anion channel (Devor et al., 1996a), although at concentrations higher than required to 
activate K+ channels. The concentration of 1-EBIO was selected because it is reported to produce 
a maximal activation of K+ channels and below the half-maximal concentration for CFTR 
activation. Exposure of the T-84 cells to 1-EBIO resulted in a variable increase in Isc that was 
consistent with SK or IK activation and transient activation of CFTR channels. Once the Isc 
attained a constant value, the monolayer was exposed to NC-1059. Exposure to the peptide was 
associated with a characteristic rapid increase in Isc within 4 min from 4 to 38 μA cm-2. 
Subsequently Isc declined toward baseline, but remained elevated at ~17 μA cm-2 for more than 
30 minutes. The magnitude of the current change generated in response to the bipolar pulse 
applied across the monolayers (represented by the vertical deflections in the Isc trace) was used to 
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calculate gte. Initially, gte was 0.5 mS cm-2 and increased to 0.75 mS cm-2 with exposure to 1-
EBIO. gte further increased immediately upon NC-1059 exposure along with the Isc, which is 
expected with the introduction of ion channels in the apical membrane. At peak Isc, gte was 2.5 
mS cm-2. However, gte continued to increase even after peak Isc was attained and during the 
decline in Isc. By the end of the recording presented in Fig. 1A, gte had increased to 21 mS cm-2. 
The results for concentration dependent effects of NC-1059 on Isc are summarized from 6 
experiments in Fig. 1B. Prior to NC-1059 exposure, Isc was 6.5 ± 1.5 µA cm-2 and maximal Isc, 
with 200 µM NC-1059, was 65.8 ± 5.2 µA cm-2 (n=6). The solid line represents the best fit of 
Eqn. 1 to the data set. Results of the fit are presented in Table 1. It is noteworthy that the fit 
employed a Hill coefficient that was greater than unity, which suggests a complex reaction 
scheme and could be indicative of the peptide’s assembly into oligomeric conductive pores. The 
average change in the gte for each concentration as a function of time is provided in Fig. 1C. The 
graph revealed that the conductance increased with peptide exposure from a value of ~1 mS cm-2 
to a maximal value in about 30 minutes and remained elevated throughout the experiment. A 
significant increase in gte was observed with 30 μM and maximal gte increased with 
concentration, reaching a maximal value at 100 μM. The peptide at 200 μM did not elicit a 
response greater than that observed with 100 μM. Parameters derived when Eqn. 2 was fitted to 
the data sets for 100 and 200 µM are reported in Table 2. The results indicate that the half-
maximal response occurred more quickly with exposure to 200 µM than 100 µM, although the 
maximal conductances were nearly identical. The time to reach half-maximal gte (t0) was greatest 
with 30 µM NC-1059 (17.1 ± 0.1 min) and decreased with increasing concentration suggesting a 
concentration dependent effect on the lag time to reach half maximal change in gte. Additionally, 
the slope (1/b) was greater for 200 μM as compared to 100 μM, further suggesting a 
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concentration dependent effect on the rate of change in gte. The peak conductance as a function 
of concentration is provided in Fig. 1D. Little change in gte was observed with 10 μM NC-1059 
as compared to untreated monolayers. The gte was significantly greater following exposure to 30 
μM NC-1059 and a maximal gte value of ~58 mS cm-2 was observed with both 100 µM and 200 
μM. The maximal gte that is reported approached the limit that the system can detect reliably. 
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 Figure 2.1: NC-1059 induces a concentration dependent elevation in Isc and gte across T-84 
monolayers. 
A) A representative trace of Isc measured from a T-84 monolayer using a modified Ussing 
chamber. The shaded bars indicate the presence of 1-EBIO (300 μM) and apical exposure to NC-
1059 (60 μM). B) Maximal Isc as a function of concentration. The symbols represent the maximal 
Isc at the concentrations tested. The solid line represents a best fit of Eqn. 1 to the data set and 
parameters of the fit are presented in Table 1. C) gte vs. time for untreated (▲), 10 (●), 30 (■), 60 
(▲), 100 (♦), 200 (▼) μM NC-1059. The solid lines represent the best fit to Eqn. 2 for the data 
set for 30, 60, 100 and 200 μM. D) The maximum gte as a function of concentration is plotted. 
Panels B, C and D represent data summarized from six observations for each concentration.  
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PVD9902 cells derived from porcine vas deferens: Fig. 2A shows a typical recording of a 
PVD9902 monolayer exposed to 60 μM NC-1059. Exposure to 300 μM 1-EBIO resulted in a 
small change in Isc but little change in gte. Subsequent exposure to 60 μM NC-1059 was 
associated with an increase in Isc from 5 to 15 μA cm-2. Isc reached a peak in less than 2 minutes 
and declined to a lower, but still elevated level. There was an increase in gte from 0.17 to 1.2 mS 
cm-2 and gte remained elevated throughout the recording. Average maximal Isc as a function of 
concentration is summarized from 6 experiments in Fig. 2B. In PVD9902 cell monolayers, the 
average Isc prior to NC-1059 exposure, but after exposure to 1-EBIO, was 4.0 ± 0.4 μA cm-2 and 
a significant effect of the peptide on Isc was observed at 60 μM with greater responses at 100 μM 
and 200 μM. The change in Isc did not show any indication of a plateau within this concentration 
range of NC-1059 and hence the fit to Eqn. 1 was constrained to a maximal Isc of 100 μA cm-2. 
The solid line represents the best fit of the data with Eqn. 1 (see Table 1). Fig. 2C provides the 
concentration dependent changes in gte as a function of time with PVD9902 monolayers exposed 
to various concentrations of NC-1059. On the scale shown, no observable change in gte was seen 
with either 30 or 60 μM. A significant change in gte was observed at 100 μM and gte was nearly 
three-fold greater with 200 μM. The parameters derived from the fit of Eqn. 2 (Table 2) showed 
that PVD9902 monolayers exposed to 200 μM NC-1059 reached half maximal gte more rapidly 
than at 100 μM with a difference that was nearly 10 min. Also the slope (1/b) derived from the fit 
was steeper for 200 μM than 100 μM. The gte began to decline gradually which limited the 
duration of the fit. The peak conductance as a function of concentration in PVD9902 is provided 
in Fig. 2D. Again no significant differences in gte were observed for concentrations ≤ 60 μM. As 
shown in Fig. 2C and D, substantial increases in gte occurred following exposure to 100 μM NC-
1059 with even greater effect at 200 μM. 
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Figure 2.2: NC-1059 induces a concentration dependent elevation in Isc and gte across 
PVD9902 monolayers. 
A) A representative trace of Isc measured from a PVD9902 monolayer using a modified Ussing 
chamber. The shaded bars indicate the presence of 1-EBIO (300 μM) and apical exposure to NC-
1059 (60 μM). B) Maximal Isc as a function of concentration. The symbols represent the maximal 
Isc at the concentrations tested. The solid line represents the best fit of Eqn. 1 to the data set. 
Parameters of the function are presented in Table 1. C) gte vs. time for untreated (▲), 10 (●), 30 
(■), 60 (▲), 100 (♦), 200 (▼) μM NC-1059. The solid lines represent the best fit to Eqn. 2 for the 
data set of 100 and 200 μM. D) The maximum gte as a function of concentration is plotted. 
Panels B, C and D represent data summarized for six observations at each concentration. 
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IPEC-J2 cells derived from porcine jejunum: Fig. 3 provides typical and summarized results for 
concentration dependent effects of NC-1059 on IPEC-J2 monolayers. Fig. 3A is a trace of an 
IPEC-J2 monolayer exposed to 60 μM NC-1059. When exposed to 300 μM 1-EBIO the 
monolayer exhibited no change in Isc. Peptide exposure resulted in an increase of Isc from a basal 
value of less than 1.0 to 5.5 μA cm-2. Isc increased to a maximal value and then declined, but not 
to baseline. The gte increased to reach a peak value of 2.34 mS cm-2 and returned towards 
baseline within 30 minutes of peptide addition. Fig. 3B provides a summary of the concentration 
dependent effects of NC-1059 on maximal Isc from 6 experiments. IPEC-J2 cells showed 
significant increases in maximal Isc at 60 μM and greater change at 100 µM and 200 μM. The 
increase in maximal Isc between 30 μM to 200 μM was almost linear with a nearly three-fold 
difference between 100 and 200 μM. The Isc did not appear to reach a maximal value within the 
tested concentration range. Hence, Eqn. 1 was fitted to the data with the maximal Isc constrained 
to100 μA cm-2 (Table 1). IPEC-J2 cells showed a significant increase in gte with 100 and 200 μM 
NC-1059 and the gte reached a peak in 20 minutes or less and then began to decline towards 
baseline (Fig. 3C). This rapid decline in gte after reaching a peak value was a common pattern 
observed with all concentrations of NC-1059 tested in IPEC-J2 monolayers. Although there is a 
modest decline in gte in PVD9902, a pronounced decline is observed only in IPEC-J2 
monolayers. The average time to reach half maximal gte (t0), derived from the best fit with Eqn. 2 
(Table 2) was several minutes greater for 100 μM as compared to 200 μM and slope was less for 
100 μM when compared to 200 μM. The calculated constants from the fit (Table 2) suggest a 
concentration dependent change in gte. The peak change in gte as a function of concentration in 
IPEC-J2 is shown in Fig. 3D. The change in gte was nearly three-fold greater at 200 μM as 
compared to 100 μM. The difference in peak gte between 100 and 200 μM was similar to the 
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pattern observed with PVD9902 monolayers, but the peak gte after exposure to NC-1059 is at 
least 50% lower than other epithelia for each concentration. It is also noteworthy that the graph 
does not reach a plateau for the concentrations tested indicating that with higher concentration of 
peptide a response comparable to other epithelia may be attained. 
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Figure 2.3: NC-1059 induces a concentration dependent change in Isc and gte across IPEC-
J2 monolayers. 
A) A representative trace of Isc measured from IPEC-J2 monolayers using a modified Ussing 
chamber. The shaded bars indicate the presence of 1-EBIO (300 μM) and apical exposure to NC-
1059 (60 μM). B) Maximal Isc as a function of concentration. The symbols represent the maximal 
Isc at the concentrations tested. The solid line represents a best fit of Eqn. 1 to the data set. 
Parameters of the function are presented in Table 1. C) gte vs. time for untreated (▲), 10 (●), 30 
(■), 60 (▲), 100 (♦), 200 (▼) μM NC-1059. The solid lines represent the best fit to Eqn. 2 for the 
data set of 100 and 200 μM. D) The maximum gte as a function of concentration is plotted. 
Panels B, C and D represent data summarized for six observations at each concentration. 
 
. 
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Calu-3 cells from human airway: In Fig. 4A, a Calu-3 monolayer was exposed to 300 μM 1-
EBIO and this resulted in a 30 μA cm-2 increase in Isc that declined only modestly. Subsequent 
exposure to 60 μM NC-1059 increased the Isc by only 7 μA cm-2 and there is no significant 
change in gte. The average Isc across Calu-3 monolayers after exposure to 1-EBIO and prior to 
addition of NC-1059 was 22 ± 5.0 μA cm-2 and after exposure to 100 μM NC-1059, the average 
Isc reached 29 ± 6.5 μA cm-2 and 37 ± 5.5 μA cm-2 at 200 µM (n=6; Fig. 4B). A fit of Eqn.1 to 
the data set was not feasible as there was a very small change in the Isc over the concentration 
range tested. Calu-3 cells showed an increase in gte (Fig. 4C) after addition of NC-1059 that was 
relatively small when compared to the change in gte observed for the other epithelia that have 
been studied. The parameters derived from the sigmoidal fits showed small differences in t0 for 
100 and 200 μM NC-1059 and the values for slope, were indistinguishable. The average peak gte 
as a function of concentration is shown in Fig. 4D. The gte at 200 μM was variable and therefore 
not significantly different than the gte at 100 μM. 
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Figure 2.4: NC-1059 induces a change in Isc and gte in Calu-3 monolayers. 
A) A representative trace of Isc measured from Calu-3 monolayers using a modified Ussing 
chamber. The shaded bars indicate the presence of 1-EBIO (300 μM) and apical exposure to NC-
1059 (60 μM). B) Maximal Isc as a function of concentration. The symbols represent the maximal 
Isc at the concentrations tested. C) gte vs. time for untreated (▲), 10 (●), 30 (■), 60 (▲), 100 (♦), 
200 (▼) μM NC-1059. The solid lines represent a best fit of Eqn. 2 for the data set of 100 and 
200 μM. D) The maximum gte as a function of concentration is plotted. The figures B, C and D 
represent data summarized from six experiments. 
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Table 1: Parameters derived from the fit of the modified Hill equation. 
 
 Initial Values Following 1-EBIO Parameters derived with Eqn. 1 
Cell line 
Isc 
(µA) 
gte 
(mS) 
Isc 
(µA) 
gte 
(mS) 
∆Isc max 
(μA) 
kapp 
(μM) 
Hill 
coefficient
    T-84 2.32 ± 0.38 0.87 ± 0.24 6.56 ± 1.50 1.65 ±0.67 79.1± 31.8  91.1 ±  54.8  1.4 ± 0.7 
PVD9902 
 
1.99 ± 0.25 
 
 
0.17 ± 0.02 
 
3.98 ± 1.10  0.23 ±1.05 *100 ± 52  152 ± 73   2.5 ± 1.1
 IPEC-J2 
 
0.82 ± 0.05 
 
 
0.14 ± 0.01 
 
0.70 ± 0.44  0.29±0.06 *100 ±324  256 ± 743   2.0 ± 2.0
  Calu-3 
 
7.56 ± 2.45 
 
 
2.33 ± 0.40 
 
21.76 ± 5.03  2.26 ±0.33     
* values constrained during fitting 
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Table 2: Parameters derived from the sigmoidal fit of gte as a function of time for each 
concentration. 
 
 
  Tissue 
   Max gte 
     (mS) 
   100μM 
   Max gte 
    (mS) 
   200μM 
b 
(min) 
100μM 
       b 
     (min) 
    200μM 
       t0 
    (min) 
    100μM 
       t0 
    (min) 
    200μM 
     T-84   58.6 ± 5.3  58.1 ± 1.9   5.8 ± 1.2   3.8 ± 0.3  14.2 ± 1.2   8.4 ± 0.4 
  PVD9902   18.1 ± 1.5  51.3 ± 2.4   5.2 ± 1.07   2.4 ± 0.4  16.7 ± 1.1  6.7 ± 0.4 
   IPEC-J2     9.8 ± 0.4  25.2 ± 1.3   3.0 ± 0.3   1.8 ± 0.3  12.6 ± 0.3   7.7 ± 0.4 
   Calu-3     2.0 ± 0.7  11.0 ± 3.1   4.1 ± 1.84   4.7 ± 3.4  18.2 ± 2.0  14.2 ± 1.9 
* Parameters refer to Equation 2 
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NC-1059 allows for the permeation of variously sized dextran through different epithelial 
monolayers. The increase in gte reported above might suggest an increase in paracellular 
permeability. However the electrical parameter cannot differentiate transcellular versus 
paracellular conductance. Hence, dextran of various sizes was used to assess permeation through 
the paracellular pathway. Additionally, since there were distinct differences in the gte before and 
after exposure to NC-1059, variously sized dextran was used to observe if these differences are 
reflected in the size selectivity to uncharged solutes.  
The effects of NC-1059 on gte of the various epithelia studied suggest a reduction in the 
paracellular barrier properties of these epithelia. MDCK monolayers treated with 100 µM NC-
1059 showed an increase in permeation of 9.5 kDa, but not 77 kDa dextran by about 5-fold 
(Broughman et al., 2004). EDTA, an agent that disrupts epithelial monolayers, showed a much 
greater enhancement of permeation. In order to test the effect of NC-1059 on the paracellular 
route of additional cell types, the permeation of 10, 20, 40 and 70 kDa dextran was determined 
over a duration of 1 hour across several different epithelia (Fig. 5). Permeation across 
monolayers exposed to 200 µM NC-1059, 5 mM EDTA or vehicle control was measured. The 
permeable support was freely permeable to all sizes of dextran tested (Broughman et al., 2004). 
NC-1059 and EDTA enhanced permeation to various sizes of dextran in all cell types tested. The 
epithelia differed in the amount of dextran that permeated in each case and in the pattern of 
permeation relative to solute size. Results specific to each cell type are presented below. Results 
presented are summarized from 3 experiments for each cell type. 
T-84: In untreated T-84 monolayers, the permeation of dextran decreased with an increase in 
size. Based on Fick’s law, this pattern of permeation cannot be attributed solely to diffusion rate 
and might be influenced by geometric constraints based on composition and length of the 
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intercellular space as suggested to be the case with MDCK monolayers (Spring, 1998; Spring & 
Hope, 1978). The permeation of dextran (all sizes tested), was significantly greater across T-84 
monolayers when treated with NC-1059 as compared to untreated monolayers. The average 
permeation of 10 kDa dextran in the presence of NC-1059 was greater by 4-fold relative to 
untreated monolayers and was comparable with previously published observations with MDCK 
monolayers (Broughman et al., 2004). Permeation of 20, 40 and 70 kDa dextran was 4 to 9-fold 
greater in NC-1059 treated monolayers than in untreated monolayers. EDTA exposure allowed 
for permeation of all sizes of dextran, although the relative permeation was increased less than 2-
fold for 10 kDa dextran and about 4-fold for 20 kDa dextran. There was a modest effect of 
EDTA on the permeation of 10 and 20 kDa dextran as compared to permeation after exposure to 
NC-1059. However the permeation of 40 and 70 kDa dextran was much greater in the presence 
of EDTA as compared to NC-1059.  
PVD9902: Permeation for all sizes of dextran tested in untreated PVD9902 monolayers was 
similar. In the PVD9902 monolayers exposed to NC-1059, the average permeation of 10 kDa 
dextran was 12-fold greater and for 20 kDa dextran, 27-fold greater than in untreated 
monolayers. It should be noted that the permeation of 20 kDa across untreated monolayers was 
less than half of the other dextran sizes; hence the fold change observed was much greater. 
Permeation of 40 and 70 kDa dextran was 4-fold and 3-fold greater in peptide treated than 
untreated monolayers respectively. NC-1059 induced a significant increase in permeation of all 
sizes of dextran. Although the permeation was enhanced for all sizes of dextran in NC-1059 
treated monolayers, the absolute and relative permeation decreased with size. This suggests that 
there is finite limit to the size of solute that can permeate the paracellular pathway when 
PVD9902 monolayers are exposed to NC-1059. Permeation for all sizes of dextran was increased 
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to a greater extent across EDTA treated monolayers than with NC-1059 treatment. This is 
consistent with EDTA induced disruption of the tight junctions. 
IPEC-J2: The permeation across untreated IPEC-J2 monolayers was comparable to PVD9902 for 
10 and 20 kDa dextran and less than the rates reported for all sizes of dextran across T-84 
monolayers. NC-1059 treatment increased the permeation of dextran across IPEC-J2 monolayers 
of 10 and 20 kDa dextran, by ~4-fold (Fig. 5C inset). The permeation of 40 kDa dextran was 
increased ~3-fold in peptide treated when compared to untreated monolayers and no NC-1059 
associated difference was observed with 70 kDa dextran. Although average permeation for most 
sizes of dextran tested in the presence of NC-1059 was enhanced several fold, the results did not 
achieve statistical significance. There was a very large increase in permeation for all sizes of 
dextran in the presence of EDTA, the largest of all cell types tested in both absolute and relative 
permeation. The results suggested that the size of the dextran molecule was the rate limiting 
factor in the permeation across NC-1059 treated monolayers. The net increase in permeation for 
20, 40 and 70 kDa dextran in IPEC-J2 monolayers treated with NC-1059 was relatively smaller 
when compared to the incremental change with PVD9902 and T-84 monolayers. 
Calu-3: Calu-3 cells allowed for substantially greater permeation of dextran molecules in basal 
conditions than the other epithelia in this study (Fig. 5D), which is consistent with the high gte 
observed in these monolayers. Since basal permeation of all sizes of dextran is relatively high, 
the average permeation of all sizes of dextran tested was enhanced only ~2-fold by NC-1059 
exposure. A significant increase in permeation as compared to untreated monolayers was 
observed only in the case of 40 kDa dextran (Fig. 5D inset). Like all other epithelia studied, 
EDTA enhanced permeation for all sizes of dextran by several fold across Calu-3 cells. 
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Figure 2.5: NC-1059 allows for the movement of uncharged molecules across epithelial 
monolayers derived from a variety of mammalian sources. 
FITC conjugated dextran of 10, 20, 40 and 70 kDa was added to the apical compartment and 
appearance of fluorescence in the basolateral compartment was quantified in the presence of one 
of three treatments (EDTA solution, NC-1059 and vehicle control as described in methods). In 
addition, dye permeation across the permeable support was quantified in the absence of cells (not 
shown). Dextran permeation was studied in the four different epithelia: T-84, PVD9902, IPEC-
J2 and Calu-3. The insets in the bottom panel show the dextran permeation for untreated and 
NC-1059 treated across IPEC-J2 and Calu-3 on a different scale. The figures A, B, C and D 
represent data summarized from three experiments (* p< 0.05 for t-test comparing untreated 
versus NC-1059 treated). 
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Taken together the results show that NC-1059 enhances the permeation of 10 to 70 kDa dextran 
across epithelial monolayers with different tissues of origin. That gte continued to increase even 
after the Isc had reached a peak value and had begun to decline suggested an increase in 
paracellular conductance. The dextran permeation results corroborate the conclusion that NC-
1059 enhances paracellular conductance in addition to the transcellular conductance. However, 
this simultaneous change in the transcellular and paracellular conductances across epithelial 
monolayers makes it difficult to isolate and quantify the changes in apical membrane 
conductance using an Ussing chamber. Therefore the two electrode voltage clamp technique was 
used to study the membrane conductance induced by NC-1059, using Xenopus laevis oocytes.  
NC-1059 increases membrane conductance in Xenopus laevis oocytes in a dose dependent 
manner and remains associated with the oocyte membrane for more than 2 hours. The dose 
dependent effect of NC-1059 on Xenopus laevis oocyte membranes was determined. A typical 
trace showing the dose dependent changes in oocyte membrane conductance is presented in Fig. 
6A. The basal conductance was 5.81 μS. Exposure to 1.25 nmoles of NC-1059 resulted in a 
pronounced increase in the membrane conductance. Once the conductance reached a plateau, the 
addition of 2.5 nmoles NC-1059 to the flowing bath solution resulted in the membrane 
conductance increasing by greater than 2-fold when compared to 1.25 nmoles. Further addition 
of 5 nmoles resulted in only a small increment in conductance. The incremental change in 
membrane conductance with each dose was relatively small until exposure to 10 nmoles. 
Addition of 10 nmoles of NC-1059 increased the oocyte membrane conductance substantially to 
199 μS. The addition of 20 nmoles of NC-1059, after the conductance reached a plateau, did not 
elicit a marked change. The data summarized from this experiment and 4 additional experiments 
(Fig. 6B) show an overall trend that follows the profile described for this typical trace. Slope 
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conductance increased from 31.8 ± 17.0 μS for 1.25 nmoles to 243.5 ± 71.2 μS at 20 nmoles 
(n=5).  
 
 
Figure 2.6: NC-1059 induces a dose dependent change in Xenopus laevis oocyte membrane 
conductance. 
A) A typical trace showing that NC-1059 induces a dose dependent change in Xenopus laevis 
oocyte membrane conductance. The arrows indicate time of addition of NC-1059 to the 
perfusion solution. B) NC-1059 induces a dose dependent change in Xenopus laevis oocyte 
membrane conductance. The recordings were made in a constantly perfused bath and bolus 
additions of the peptide were made to the bath as indicated. Slope conductance was calculated 
using linear regression of current voltage plots obtained when the current reached a plateau after 
each bolus addition. Each bar shows the average change in slope conductance from baseline 
(mean ± SEM for n=5). 
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NC-1059 had a dose dependent effect on Xenopus laevis oocytes similar to the observation that 
there was a concentration dependent effect of NC-1059 in epithelial monolayers. Thus, a second 
set of experiments was conducted to observe the stability of the NC-1059 induced conductance 
in the oocyte membrane. A typical trace showing the effect of NC-1059 on membrane 
conductance is represented in Fig. 7A. Peptide (5 nmoles) was added to the perfusion solution 
after determining the basal conductance. The conductance increased to 150 μS, and after 
reaching a plateau, the conductance remained at an elevated value during the rest of the 
recording. Data are summarized from three experiments in Fig. 7B to show that membrane 
conductance increased upon exposure to NC-1059 and then remained stable during the entire 
recording period of 2 hours. This outcome suggests that the dose dependent change in membrane 
conductance induced by NC-1059 was caused by formation of ion channels in the membrane. 
Membrane conductance reflects the aggregate value for the number of actively gating channels 
(n), the single channel conductance (gi) and the open channel probability (po) of these channels 
(gmembrane = gi . n .  po). Although these individual properties were not determined, the aggregate 
value was stable over the duration of the recording. 
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Figure 2.7: NC-1059 induces a stable change in Xenopus laevis oocyte conductance, lasting 
longer than 2 hours.  
A) A typical trace of NC-1059 induced Xenopus laevis oocyte membrane conductance as a 
function of time. B) NC-1059 induces a stable change in Xenopus laevis oocyte conductance, 
lasting longer than 2 hours. Recordings were conducted in a constantly perfused bath. The bars 
represent average (mean ± SEM for n=3) slope conductance prior to addition of peptide, slope 
conductance after 1 hour ,1.5 hours and 2 hours of peptide addition.  
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Discussion: 
The results demonstrate that NC-1059, a synthetic channel forming peptide, increased ion 
transport and solute permeation across epithelial monolayers derived from a variety of sources. 
The pattern of change in Isc and gte as a function of NC-1059 concentration was different in 
magnitude and stability for each cell type tested. Also, NC-1059 induced permeation of 10, 20, 
40 and 70 kDa dextran across the various epithelia showed distinct patterns in terms of amount 
and size of dextran that permeated. NC-1059 increased oocyte membrane conductance in a dose 
dependent manner and the induced change in conductance remained elevated for the duration of 
the recording. Taken together the results suggest that NC-1059 associates with cell membranes to 
form stable active ion channels. The results further demonstrate that the NC-1059 induced 
increase in permeation across epithelial barriers, especially through the paracellular route is not 
limited to MDCK monolayers, and can be generated in a variety of epithelia derived from 
different tissues and species. 
Epithelia were chosen to represent organs where efficient drug delivery is of clinical 
significance. The epithelia also represent a broad spectrum in terms of the degree of “tightness” 
(Furuse et al., 2001) as indicated by basal gte. The epithelia used in the study can be arranged in 
the degree of electrical tightness as IPEC-J2 > PVD9902 > T-84 > Calu-3 (see Table 1). The 
change in Isc and gte showed characteristically distinct patterns in the four epithelial monolayers 
in terms of kapp, Hill coefficient, and time taken to reach half maximal gte, slope and the 
magnitude of gte at different NC-1059 concentrations. The changes in Isc and gte observed at 
various peptide concentrations in T-84 monolayers are quantitatively and qualitatively similar to 
MDCK cells and, like MDCK cells, the kapp was less than 100 μM with T-84 cells (Broughman 
et al., 2004). However, in PVD9902 cell monolayers the Isc did not appear to reach a maximal 
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value within the concentration range tested. Hence the kapp may be greater than 100 μM. In the 
case of IPEC-J2 as well, the kapp may be greater than the reported value. Hill coefficients were 
greater than 1 for T-84 cells and greater than 2 for IPEC-J2 and PVD9902 cells. Both kapp and 
Hill coefficients follow this trend, IPEC-J2 > PVD9902 > T-84. Based on the constants derived 
from the fit of Eqn. 2, the effect of NC-1059 on gte also follows the trend IPEC-J2 > PVD9902 > 
T-84. Hence it appears that the response to NC-1059 might be influenced by basal gte. Lipid 
composition of membranes, particularly negatively charged lipids and cholesterol, have been 
shown to influence activity of synthetic channel forming peptides (Bell & Miller, 1984; Lin & 
Kagan, 2002), which might explain differences in the response between epithelia.  
NC-1059 increased epithelial dextran permeation, indicating that a paracellular route was 
accessed. In T-84 and PVD9902 monolayers, the NC-1059 induced increment in dextran 
permeation was greater for the smaller dextrans (10 and 20 kDa). Nevertheless permeation for all 
sizes of dextran was enhanced relative to untreated monolayers. IPEC-J2 cells exhibited less 
permeation when compared to other cell types. This is consistent with the observation that gte is 
nearly 50% less across IPEC-J2 as compared to PVD9902 and T-84 monolayers. Also, gte 
declined rapidly in IPEC-J2 monolayers as compared to a more sustained response observed in 
other epithelia. Since enhancing permeability of intestinal epithelia can be associated with a risk 
of infection, absorption enhancers must have a transient effect. Therefore, limited and transient 
enhancement in permeation by NC-1059 across the IPEC-J2 monolayers is a useful property 
associated with the peptide in these cells derived from the small intestine. The sustained effect 
with T-84 cells however, demonstrates that this observation cannot be extended to all intestinal 
cell types. Clearly, additional studies are required to define effects of NC-1059 on additional 
intestinal cell types and on native tissue. 
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NC-1059 produced a modest effect on ion transport across Calu-3 cell monolayers. The large and 
sustained effect of 1-EBIO supports the conclusion that CFTR is abundant and active in the 
apical membrane of unstimulated Calu-3 cells (Shen et al., 1994) and the apical conductance is 
not rate limiting for ion transport. Thus a negligible effect of NC-1059 on Isc is not unexpected. 
Nonetheless, 100 and 200 μM NC-1059 increased gte, which we interpret as an increase in 
paracellular permeability. Ultimately, the amount of dextran that permeated Calu-3 monolayers 
in the presence of NC-1059 was comparable to that observed in the other epithelia studied. The 
ability of NC-1059 to enhance permeation by 10 to 20 kDa molecules across Calu-3 monolayers 
suggests that it might be used to enhance delivery of drugs in nasal sprays or inhalers.  
NC-1059 increased paracellular passage of dextrans up to 70 kDa, although permeation was 
quite low. Larger molecules were not tested in this study. Earlier work in MDCK cells, however, 
showed no passage of 2.5 MDa dextran (Broughman et al., 2004). Taken together, the results 
suggest that permeation of small molecules (e.g., vancomycin) will be enhanced by NC-1059. 
Permeation of larger molecules such as insulin (~4 kDa) will also likely be enhanced by NC-
1059, but molecules such as albumin (67 kDa) would be expected to have limited permeability. 
Permeability of larger and potentially harmful structures such as bacteria and virus particles 
would also be expected to remain negligible. 
Epithelial cells differ in size and hence the monolayers may differ in the number of lateral 
intercellular spaces. Additionally, epithelia may differ in the composition, distribution and 
expression of the junctional proteins that maintain the integrity of the paracellular route (Acharya 
et al., 2004; Heiskala, Peterson & Yang, 2001). Both of these factors can contribute to the 
differences observed in the epithelia studied. Tight junctions are “multimolecular complexes” 
comprised of integral membrane proteins and plaque proteins. These plaque proteins are 
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associated with several cytosolic proteins and also connect the integral membrane proteins and 
perijunctional-actin cytoskeleton (Schneeberger & Lynch, 2004). These proteins have an integral 
role in regulating paracellular permeability (Anderson & Van Itallie, 1995; Furuse et al., 1996; 
McCarthy et al., 1996). Disruption of actin and the localization of junctional proteins by toxins 
such as ZOT (Fasano, 2000) reportedly resulted in increased paracellular permeability. Results in 
this paper show that NC-1059 enhances permeation through the paracellular space. The results 
suggest that, in addition to supporting ion transport across epithelial cells, NC-1059 transiently 
affects the stability or distribution of tight junction proteins. 
NC-1059 induces a rapid and dose dependent increase in membrane conductance in Xenopus 
laevis oocytes. It is noteworthy that the membrane conductance consistently changed in small 
increments until the 5 nmole dose and addition of 10 nmoles caused a more substantial change in 
conductance. Exposure to a higher dose inconsistently caused a modest change in membrnae 
conductance that did not achieve statistical significance. A possible explanation is that 10 nmoles 
establishes a critical concentration in the membrane at which individual peptide molecules are 
sufficiently close to assemble into the greatest number of functional channels and possibly to 
saturate the membrane such that further peptide exposure does not enhance conductance. 
NC-1059 induced an increase in membrane conductance that remained stable in Xenopus oocytes 
as opposed to the transient effect on Isc observed in mammalian epithelial monolayers. This 
suggests that there is a secondary event in the epithelial monolayers responsible for the decrease 
in Isc (i.e., results suggest that channel-forming peptides can remain resident in the cell 
membrane). One possibility is that NC-1059 forms channels that cause depolarization. The 
decrease in Isc may occur when cellular mechanisms are not sufficient to maintain 
electrochemical driving forces to sustain net ion transport at the peak level. Long stable 
 76
recordings with both mammalian cell monolayers and Xenopus oocytes, however, demonstrate 
that the peptide does not induce cell lysis.  
The predominant obstacle to the permeation of clinically relevant therapeutics across epithelial 
barriers is the degree of hydrophilicity and size for many of these molecules. Systemic drug 
delivery for such compounds requires larger doses of drugs and therefore is associated with 
increased costs and the potential for undesirable effects in some cases (Torchilin, 2000). Several 
oral antibiotics and antivirals have limited permeability across intestinal epithelia because of 
their hydrophilic nature and size (Peppas, Wood & Blanchette, 2004). Colonic, airway and 
corneal / conjuctival epithelia are barriers to the absorption of drugs specifically targeted to these 
tissues. The conditions that afflict the anterior portion of the eye such as glaucoma and keratitis 
are treated with drugs that must permeate through corneal or conjuctival epithelia (Edward & 
Prausnitz, 2001; Zhang, Prausnitz & Edwards, 2004). The nasal or airway epithelium is another 
major target for drug delivery as an alternative to injections of drugs such as insulin (Gonzalez et 
al., 2006; Turker, Onur & Ozer, 2004). Results presented in this paper show that NC-1059 
enhanced the permeation of molecules as large as 10 and 20 kDa across colonic (T-84), small 
intestine (IPEC-J2) and airway (Calu-3) epithelial monolayers. NC-1059 also enhanced 
permeation across kidney (MDCK) (Broughman et al., 2004) and reproductive duct (PVD9902) 
epithelial monolayers. Hence NC-1059 has potential to be developed as an absorption enhancer 
for therapeutic agents.  
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Abstract:  
The goal of this study is to identify the mechanism(s) by which NC-1059, a synthetic channel 
forming peptide, increases epithelial paracellular permeability. Apical exposure to NC-1059 (60 
μM) increased short circuit current, transepithelial electrical conductance (gte) and enhanced the 
permeation of dextrans (10-70 kDa) across MDCK monolayers, both of which returned to 
pretreatment levels within 48 hours after washout (1). MDCK monolayers in this study showed a 
large increase in gte and enhanced permeation of 40 and 70 kDa dextran. MDCK monolayers 
exposed to 100 and 200 μM NC-1059 for 60 min showed a substantial recovery in gte at 24 hours 
and returned to pretreatment values within 48 hours. MDCK monolayers exposed to NC-1059, 
when subjected to immunolabeling and confocal microscopy, revealed a concentration dependent 
reorganization or loss of actin, ZO-1 and occludin over 60 min. NC-1059 also causes a decrease 
in abundance of E-cadherin and β-catenin over 60 min. Effects of NC-1059 exposure were 
reversible with progressive recovery of immunoreactivity at the apical cell junction for occludin 
and ZO-1 observed 24 and 48 hour post exposure. The modulation of the epithelial tight 
junctions in a reversible manner indicates that NC-1059 has therapeutic potential to increase the 
efficiency of drug delivery across barrier membranes. 
Key words: Occludin, ZO-1, Actin, Paracellular permeability, Transepithelial conductance, 
Madin Darby Canine Kidney cells 
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Introduction: 
NK4-M2GlyR (KKKKPARVGLGITTVLTMTTGSSGSRA) is a channel forming peptide that 
was synthesized by adding four lysine residues to the second transmembrane segment (M2) of 
the glycine receptor (GlyR) alpha-subunit (2, 32, 35) and was shown to increase anion secretion 
by epithelial monolayers. However, the subsequent removal of up to five C-terminus residues of 
NK4-M2GlyR reduced aggregation of the peptide in aqueous solution while retaining ion 
transport properties (2). Based on the hypothesis that only the N-terminus half of the peptide was 
necessary for its ion transport properties, a palindromic peptide was designed with 11 residues 
from the N-terminal half of NK4-M2GlyR. The final sequence, 
KKKKAARVGLGITTVLVTTIGLGVRAA, was termed NC-1059. 
NC-1059 enhances ion transport and reduces barrier function of epithelial monolayers. MDCK 
monolayers that were exposed to NC-1059 apically showed a concentration dependent increase 
in short circuit current (Isc) demonstrating an increase in anion secretion or cation absorption. 
The transepithelial conductance (gte), a measure of epithelial barrier function, also increased in a 
concentration dependent manner (1). Furthermore, NC-1059 enhanced the permeation of 9.5 kDa 
dextran, showing that a paracellular route was opened (1). The effect of the peptide on gte and 
paracellular solute movement was reversed within 48 hours of returning the monolayers to fresh 
media. The cell monolayers regained responsiveness to subsequent treatments with the peptide 
(1). Thus the effects of NC-1059 on epithelial monolayers are reversible and repeatable. 
Epithelial cell layers act as barriers to the movement of hydrophilic or uncharged molecules. The 
intercellular contacts between epithelial cells are called tight junctions and play a critical role in 
the barrier function. Tight junctions are “multimolecular complexes” located between the apical 
intercellular regions of both epithelial and endothelial cells that regulate paracellular 
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permeability (29). Occludin, claudins, junctional adhesion molecule-1 (JAM-1) and zona 
occludens protein-1 (ZO-1), along with other proteins form the tight junctions (29). The tight 
junction complex associates with the perijunctional actomyosin ring and this complex is 
proposed to be involved in regulation of the movement of solutes through the paracellular route 
(18). Compounds such as bacterial and fungal toxins (e.g., Clodtridium difficle toxins, 
ochratoxin), positively charged molecules (e.g., protamine) and chitosans are amongst several 
molecules observed to cause an increase in gte through an effect on actin organization and /or 
localization of junctional proteins (20, 22, 25, 28). Peptides corresponding to the first and second 
extracellular loops of occludin also increased paracellular permeability. However they required 
several hours to produce significant effects (5, 36). More recently, a modified occludin peptide 
reportedly enhanced permeability across airway epithelia and caused a more rapid loss in 
localization of occludin at the tight junctions (31). The zonula occludens toxin of Vibrio cholerae 
(ZOT) is a naturally occurring peptide that increases the permeability of small intestine epithelia 
(10). ZOT is rapid in onset (< 20 min) and reversible. ZOT causes reorganization of actin and a 
change in the localization of ZO-1 (9). VP8, a rotavirus surface protein, enhances paracellular 
permeability by causing a redistribution of occludin, ZO-1 and claudin-3 at the tight junctions in 
MDCK monolayers (23). These results suggest that the actin cytoskeleton and the proteins 
comprising the tight junctions can be modulated either in distribution or abundance to affect 
epithelial barrier function. 
Adheren junctions also contribute to the epithelial barrier. E-cadherin is a transmembrane 
adheren junction protein that associates with the actin cytoskeleton through β-catenin. These 
interactions are important in maintaining cell morphology and paracellular permeability (15). 
Additionally E-cadherin and β-catenin are important players in the assembly of the tight 
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junctions (14, 26). Disruption of E-cadherin is associated with an increase in paracellular 
permeability with an associated change in F-actin organization and organization of other 
junctional proteins (37-39). Hence a pronounced reorganization in F-actin might involve a 
change in distribution of E-cadherin and β-catenin. 
The focus of this study is to establish the underlying microscopic mechanisms by which NC-
1059 enhances the permeability across MDCK monolayers. We hypothesized that NC-1059 
alters the localization of one or more junctional proteins. Also, since the actin cytoskeleton plays 
a significant role in regulating paracellular permeability, NC-1059 may induce changes in 
permeability by altering actin organization. This study determined the effects of selected NC-
1059 concentrations on actin organization and the localization or abundance of occludin and ZO-
1 over time. The study also evaluated the effects of NC-1059 on localization and abundance of 
adheren junction molecules E-cadherin and β-catenin. Finally the study also assessed the time 
course of recovery in the gte and the pattern of the localization of the junctional proteins as the gte 
recovered. 
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Methods: 
Peptide Synthesis: NC-1059 was synthesized as described previously, by solid phase synthesis 
using 9-fluorenylmethoxycarbonyl chemistries (3). The peptide was purified by reversed-phase 
HPLC and characterized by Edman degradation and matrix-assisted laser desorption time of 
flight mass spectroscopy (3). 
Chemicals: A 4% paraformaldehyde solution in phosphate buffered saline (PBS) was prepared 
from a 16% paraformaldehyde stock (Electron Microscopy Sciences, Hatfield, PA). Peptide 
stocks of 5 mM or 8 mM were prepared in deionized water just prior to use. Unless otherwise 
indicated, chemicals used were reagent grade obtained from Sigma Aldrich (St. Louis, MO). 
Cell culture: MDCK cells were obtained from Dr. Lawrence Sullivan (University of Kansas 
Medical Center, Kansas City, KS) and maintained in culture as described previously (1, 2). Cells 
were grown on 25 cm2 flasks (Corning Incorporated, Corning, NY) with a medium containing a 
1:1 mixture of Dulbecco's modified Eagle medium and Nutrient F12 (GIBCO, Invitrogen, 
Carlsbad, CA), 5% heat inactivated fetal bovine serum (Atlanta Biologicals, Atlanta, GA) and 
1% penicillin and streptomycin. Cells were maintained in a humidified incubator with 5% CO2 at 
37˚C. Cultures that were 90 to100% confluent were treated with 0.25% trypsin and 2.6 mM 
EDTA (GIBCO) and gentle mechanical force was used to dislodge cells from the surface. 
Approximately 5*105 cells were seeded onto 1.13cm2 permeable supports (Snapwell, Costar, 
Corning Incorporated). A tenth of the cells were also seeded onto flasks to further passage. The 
media were refreshed every alternate day. 
Electrical Measurements: Isc and transepithelial electrical potential were measured using a 
modified Ussing Chamber (model DCV9, Navicyte, San Diego, CA) as described previously (1, 
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2). Monolayers were bathed symmetrically with Ringer solution (in mM: 120 NaCl, 25 NaHCO3, 
3.3 KH2PO4, 0.8 K2HPO4, 1.2 MgCl2, and 1.2 CaCl2) that was prepared fresh daily, maintained 
at 37˚C and bubbled with 5% CO2/ 95% O2 to maintain pH. The monolayers were clamped to 0 
mV and a 5 s 1 mV bipolar pulse was applied every 100 s using a voltage clamp (model 558C-5, 
University of Iowa, Dept. of Bioengineering, Iowa City, IA). Data acquisition was performed at 1 
Hz using an Intel based computer and MP100A-CE interface (v. 3.2.6, BIOPAC Systems, Santa 
Barbara, CA). The current measured in response to the voltage pulse was used to calculate gte 
(Ohms law, gte = ∆I/∆V). 
FITC-Dextran permeability assay: Dextran permeation through the monolayer was measured as 
described previously (1). The medium was removed and the monolayers were washed with 
warmed PBS. Ringer solution was added to the basolateral (1 mL) and apical (200 μL) 
compartments in the Snapwell culture plate. NC-1059 or vehicle control was added to the Ringer 
solution on the apical side of the monolayers to result in a final concentration of 200 μM NC-
1059. Monolayers were exposed to 5 mM EDTA in hypotonic Ringer solution (50 % dilution 
with water). Dextran (40 or 70 kDa) conjugated to FITC (0.5 mg) was added to the apical 
compartment of all treatments. After incubation at 37˚C for 1 hour samples were taken from the 
basolateral compartment for determination of fluorescence intensity (Fluorskan Ascent FL, 
Thermo Fisher Scientific, Waltham, MA). A series of dilutions of each size of dextran was 
prepared and fluorescence determined as a function of concentration. A linear regression was 
used to derive the slope and calculate the amount of dextran that permeated the monolayer.  
Immunolabeling: MDCK monolayers were exposed to 200 μM NC-1059 for 5, 15, 30 and 60 
min. NC-1074 (KKKKARSGSSQTTMTLARSGSSQTTMT), a peptide that does not elicit the 
changes in epithelial electrical parameters, or vehicle control was used as a negative control. In a 
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second set of experiments, concentration dependent effects were assessed by exposing MDCK 
monolayers to 100 μM or 200 μM NC-1059 for either 30 or 60 min. After the indicated 
treatments, the monolayers were fixed with 4% paraformaldehyde. Fixed monolayers were 
incubated with anti-occludin (Zymed, Carlsbad, CA) or anti-ZO-1 (Chemicon, Temecula, CA 
and Zymed) antibodies and with Alexa 488 conjugated phalloidin (Molecular Probes, Carlsbad, 
CA). In another set of experiments, MDCK monolayers were exposed to vehicle or 200 μM NC-
1059 for 30 or 60 min. Monolayers were subsequently fixed and labeled with anti-E-cadherin 
(Hybridoma bank, University of Iowa, Iowa City, IA) or anti-β-catenin (BD Biosciences) 
antibodies. The secondary antibodies were conjugated to Alexa 488 (green), Alexa 594 (Red) or 
rhodamine (Red). TOPRO-3 (blue; Molecular Probes) was used to label the nucleus. Images 
were acquired using a confocal microscope (LSM 510, Carl Zeiss AG, Jena, Germany). Optical 
sections (0.8 μm) were obtained along the Z-axis from the apical to basolateral aspect of the cells 
to make a Z-stack. 3-D projection was used to obtain a composite view of selected regions within 
the Z-stack.  
Immunoblotting: Proteins were extracted from MDCK monolayers following exposure to 100 or 
200 μM NC-1059 or vehicle control for 30 or 60 min. Monolayers were subject to lysis using 
RIPA buffer (composition: 150 mM NaCl, 10 mM HEPES, 2 mM EDTA, 1% Triton X-100, 
0.2% SDS, 0.5% sodium deoxycholate) with protease inhibitor cocktail III (Calbiochem, San 
Diego, CA) and Halt phosphatase inhibitor cocktail (Pierce, Rockford, IL) and the lysate was 
passed repeatedly through a 21 gauge needle. The lysate was incubated at 4˚C for 1 hour and 
then centrifuged at 4˚C and 14,000g for 15 min. The supernatant was collected and protein 
concentration determined using the bicinchoninic acid (BCA) method using albumin as standard 
(Pierce). The supernatants were mixed with 5x Lamelli sample buffer (250 mM Tris base, 40% 
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glycerol, 0.8% SDS, 20% β- mercaptoethanol and 0.01% bromophenol blue) and equal amounts 
of protein (15 to 35 μg) for each treatment were loaded onto 4-15% gel (Biorad, Hercules, CA) 
and resolved at a 140 mV for 1 hour using a running buffer (25 mM Tris Base, 200 mM Glycine, 
0.1 % SDS). Proteins were transferred onto Immobilon–P transfer membrane (Millipore, 
Billerica, MA) overnight at 350 mA with transblot buffer (25 mM Tris base, 192 mM glycine, 
20% v/v methanol). The membranes were blocked with 5% blotting grade milk (Biorad) in TBS 
(20 mM Tris base, 0.8% NaCl, pH 7.6) with 0.1% Tween-20 for 2 hours. Subsequently, the 
membranes were probed with either anti-occludin Mab (BD Biosciences, San Jose, CA), anti-
ZO-1 Mab (Zymed), anti-E-cadherin (Hybridoma bank, University of Iowa, Iowa City, IA), anti-
β-catenin (BD Biosciences) or anti-GAPDH Mab (Abcam, Cambridge, MA). HRP conjugated 
anti-rabbit and anti-mouse secondary antibodies (Amersham Biosciences, Piscataway, NJ) were 
used for detection. Chemiluminiscent substrate Super Signal West Pico and Femto (Pierce) were 
used for development. Images were obtained using the Kodak Imaging System (Kodak Image 
Station 4000 R, Kodak, Rochester, NY) and densitometric analysis (Kodak molecular imaging 
software v 4.5.0) was used to compare labeling intensity. Normalized intensity is the net 
intensity of the signal detected for each epitope and each treatment presented as a percentage of 
the net intensity detected for the corresponding GAPDH immunoreactivity in each lane. 
Recovery experiments: Monolayers were mounted into modified Ussing chambers and Isc and gte 
measured as described. Monolayers were exposed to 100 or 200 μM NC-1059 or vehicle (Ringer 
solution) for 60 min and returned to the incubator for either 24 or 48 hours before gte was assessed 
again. Each set of monolayers was fixed subsequently with 4% paraformaldehyde and labeled 
with anti-occludin and anti-ZO-1 antibodies as described.  
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Data analysis: All numerical results are reported as mean ± SEM. All graphs and regression fits 
were completed using Sigmaplot 2000 (v 6.0, SPSS Inc, Richmond, CA) and/or Excel (v 11.8, 
Microsoft Corp, Redmond, WA). The student’s t-test (Sigmaplot) and ANOVA (Excel) were 
used for statistical analysis where required. The time course for NC-1059 induced changes in gte 
was determined by fitting a sigmoidal function (Eqn. 1) to values of gte that were calculated 
every one hundred seconds throughout each experiment using the time of NC-1059 exposure as 
the starting point (i.e, t=0).  
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 Eqn. 1 
In Eqn. 1, gte min is the baseline conductance and Δgte max is the peak change in conductance 
reached during the recording for each NC-1059 concentration. b is inversely proportional to the 
slope at half Δgte max and t0 is the time taken to reach half Δgte max. The data used for the fit were 
restricted to ~ 300 s after the peak gte was reached. 
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Results: 
NC-1059 induces a concentration dependent change in gte. 
The average change in the gte in response to 100 and 200 μM NC-1059 as a function of time is 
provided in Fig. 1. The graph reveals that the conductance increased with peptide exposure from 
a value of 0.56 ± 0.09 mS cm-2 to a maximal value in about 30 min and remained elevated 
throughout the experiment. A significant increase in gte was observed with 100 μM (8.52 ± 1.17 
mS cm-2) and several fold greater response was observed with 200 μM (32.32 ± 1.18 mS cm-2) 
NC-1059. The results indicated that the half-maximal response occurred more quickly as 
indicated by lag time (t0) and slope (b) with exposure to 200 µM (t0 = 14.60 ± 0.57 and b = 4.71 
± 0.51 min) as compared to 100 µM NC-1059 (t0 = 23.36 ± 0.97and b = 7.01 ± 0.97 min). 
 
 
Figure 3.1: NC-1059 induces a concentration dependent change in gte. 
The figure shows the average change in gte with 100 μM (■) and 200 μM (▲) NC-1059 as a 
function of time. The solid lines represent the best fit to Eqn. 1 to each data set. Results are 
summarized from n=3. 
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gte is a composite measure of the transcellular and paracellular conductances. The substantial 
increase in gte after exposure to NC-1059 is consistent with the introduction of ion channels in 
the apical membrane and suggests that a paracellular route is opened as reported previously (1). 
gte is a measure of the movement of ions (< 100 kDa) although larger solutes might also 
permeate. Previously published observations indicate that exposure of MDCK monolayers to 60 
μM NC-1059 resulted in a 5 fold increase in permeation of 9.5 kDa dextran (1). Permeation of 
molecules as > 77 kDa was not enhanced by the presence of NC-1059 (1). However, further 
experiments conducted with other epithelial cell types showed that 200 μM NC-1059 enhanced 
permeation of 40 and 70 kDa dextran (30). Hence experiments were conducted to measure 
permeation of intermediate sizes of dextran across MDCK monolayers, in the presence of NC-
1059. 
NC-1059 allows for the permeation of 40 and 70 kDa dextran across MDCK monolayers. 
Dextran permeation across monolayers exposed to vehicle, 200 µM NC-1059 or EDTA over 
duration of 1 hour was measured (Fig. 2). Monolayers exposed to EDTA showed a large 
enhancement in permeation for both 40 and 70 kDa dextran relative to vehicle treated 
monolayers. NC-1059 also enhanced permeation of 40 and 70 kDa dextran relative to vehicle 
treated monolayers. However the fold enhancement is small compared to EDTA, a compound 
that has a disruptive effect on epithelia. These results support observations made with other cell 
types (30) and indicate that the paracellular route is partially opened to allow permeation by 
various size dextans across MDCK monolayers. 
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Figure 3.2: NC-1059 allows for the movement of uncharged molecules across MDCK 
epithelial monolayers. 
FITC conjugated dextran of 40 and 70 kDa was added to the apical compartment and appearance 
of fluorescence in the basolateral compartment was quantified in the presence of one of three 
treatments (EDTA, NC-1059 and vehicle control as described in methods). Results are 
summarized from n=3. 
 
The cell cytoskeleton, particularly its key component actin, along with associated junctional 
proteins regulates movement of ions and solutes through the paracellular route. Therefore tests 
were conducted to determine the effect of NC-1059 on the distribution and abundance of actin 
and the junctional proteins, occludin and ZO-1.   
NC-1059 exposure causes a reorganization of actin: Experiments were conducted to determine 
the effect of NC-1059 on actin organization as a function of time (Fig. 3A). Images of the F-actin 
labeled monolayers were obtained as optical sections along the Z-axis. Sections of the Z-stack 
were divided into apical, middle and basal regions and each panel presented in the figure is a 
composite projection of these 4-6 optical sections. F-actin fibers are present throughout all 
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portions of all cells in the monolayer. Each cell is clearly circumscribed by the perijunctional 
actomyosin ring in the apical region. There is also central punctate staining of F-actin fibers in 
the apical region. The middle and basal sections show cortical actin filaments. In the most basal 
sections, actin filaments appear bundled and might constitute stress fibers. Exposure of the 
monolayer to 200 μM NC-1059 for 5 min showed little change in the F-actin labeling along the 
entire depth of the monolayer. The intensity of the labeling of central actin fibers and 
perijunctional actomyosin ring in some areas was clearly reduced at 15 min. The images (Fig. 
3A) clearly show regions of the monolayer in which the apical sections exhibited no labeling 
while adjacent cells remained fully circumscribed. After 30 min of NC-1059 exposure an overall 
decrease in intensity of F-actin labeling was observed in the apical, middle and basal sections of 
the Z-stack. Relative to the 15 minute time point, larger regions of the monolayer were devoid of 
F-actin labeling especially at the apical regions. At the same time, the labeling of the 
perijunctional actomyosin actin ring was intensified in the remaining cells. After 60 min of NC-
1059 exposure the labeling of apical actin fibers was dramatically reduced. There was a 
reduction in the punctate labeling of F-actin fibers apically and also a pronounced decrease in 
intensity of labeling of the perijunctional actomyosin actin ring. There was also a pronounced 
reduction in the labeling of fibers in the middle and basal portions of the cells. The reduction in 
the intensity of labeling both at the perijunctional actomyosin ring and F-actin fibers throughout 
the Z-stack suggested a disruption in the organization of the actin cytoskeleton in NC-1059 
treated monolayers. Monolayers exposed to 200 μM NC-1074, a scrambled sequence of NK4-
M2GlyR that does not elicit any changes in ion transport, showed a labeling pattern for F-actin 
comparable to vehicle exposed monolayers. This suggests that the effect on actin organization 
was specific to the NC-1059 sequence.  
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NC-1059 has a concentration dependent effect on gte and it is likely that the effect of NC-1059 
on actin organization might also follow a concentration dependent pattern. The effect of 100 and 
200 μM NC-1059 on actin organization in MDCK monolayers reveal that there is no discernable 
difference in the effect of both concentrations on actin organization (Fig. 3B). Exposure of 
monolayers to 100 μM NC-1059 for 30 min caused a reduction in the labeling of the actin fibers 
along all regions of the Z-stack. There was a decrease in the intensity at the perijunctional 
actomyosin ring and reduction in the central F-actin fibers along the apical sections. There was 
also reduction in labeling of the actin fibers along the middle and basal sections. Large areas 
showed a pronounced decrease in intensity of F-actin labeling, both centrally and along the 
perijunctional actomyosin ring. However, some cells exhibited an enhanced intensity especially 
along the perijunctional actomyosin ring. After 60 min of exposure with 100 μM NC-1059, there 
was a significant decrease in intensity and labeling of F-actin throughout most cells. The results 
observed with 200 μM NC-1059 were consistent with observations made in the previous 
experiment at the corresponding time points. The middle and basal sections show a further 
decrease in labeling intensity after 60 min of exposure with both concentrations. However it 
might be noted that after 60 min of exposure to 200 μM NC-1059, the labeling of the 
preijuntional actomyosin ring although substantially decreased in intensity, is still circumscribing 
all cells. 
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Figure 3.3: NC-1059 causes a reorganization of actin. 
A) Time course of the effects of NC-1059 on actin organization. Panels show images of 
monolayers labeled with Alexa conjugated phalloidin. Images show typical F-actin labeling in 
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monolayers that were exposed to vehicle for 30 min or treated with 200 μM NC-1059 for 5, 15, 
30 or 60 min or 200 μM NC-1074 for 30 min. Images were obtained as Z-stacks using confocal 
microscopy. Images shown above are the 3-D projection of the respective Z-stacks. B) Effect of 
100 and 200 μM NC-1059 on actin organization: Monolayers were exposed to vehicle or 100 or 
200 μM NC-1059 for 30 or 60 min and labeled with Alexa conjugated phalloidin. Images were 
obtained as Z-stacks using confocal microscopy. Images shown above are the 3-D projection of 
the respective Z-stacks. In both figures, the results are a typical example of n=4 and from paired 
monolayers. 
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NC-1059 alters the distribution of occludin and ZO-1: ZO-1 and occludin associate directly and 
indirectly with actin, respectively (7, 8, 24). Thus reorganization in the actin cytoskeleton may 
alter the localization of occludin and ZO-1, which could account for changes in the integrity of 
the paracellular barrier. 
NC-1059 exposure was associated with diminished immunoreactivity of junctional proteins ZO-
1 and occludin, with a more pronounced effect on ZO-1 (Fig. 4A). Monolayers that were 
exposed to vehicle and labeled with anti-occludin (green) and anti-ZO-1 (red) antibodies showed 
strong immunoreactivity in the apical region of the MDCK monolayers. ZO-1 and occludin 
localized at the tight junctions along cell-cell contact regions, as expected, and the proteins 
appeared to colocalize, as shown in the merged image. Exposure of MDCK monolayers to 200 
μM NC-1059 for 5 min and 15 min showed apparent reduction in the intensity of labeling 
relative to vehicle treated monolayers. A pronounced reduction in ZO-1 immunoreactivity was 
observed within 30 min of exposure. After 30 min of exposure there was not only a reduction in 
intensity of ZO-1 labeling, but there appeared to be an absence of labeling in several areas of the 
monolayer. Occludin immunoreactivity appeared to be slightly reduced in intensity, albeit to a 
less pronounced extent when compared to ZO-1. After 60 min, immunoreactivity to ZO-1 was 
negligible and the labeling for occludin appeared to be discontinuous with a pronounced 
reduction in intensity. Immunoreactivity to anti-occludin and anti-ZO-1 antibodies in monolayers 
that were exposed to 200 μM NC-1074 for 30 min was comparable to vehicle. 
The decrease in immunoreactivity of the junctional proteins followed a concentration dependent 
pattern in MDCK monolayers (Fig. 4B). Monolayers were exposed to 100 and 200 μM NC-1059 
or vehicle for 30 or 60 min. Monolayers that were vehicle treated for 30 or 60 min showed 
comparable pattern of labeling for both occludin and ZO-1 immunoreactivity. Exposure to 200 
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μM NC-1059 resulted in substantially diminished immunoreactivity for occludin and ZO-1 
within 30 min. Monolayers exposed to 100 μM NC-1059 for 30 min showed immunolabeling for 
both ZO-1 and occludin comparable to a monolayer that was exposed only to vehicle for 30 min. 
After 60 min of treatment both 100 and 200 μM NC-1059 showed a pronounced decrease in ZO-
1 immunoreactivity and a discontinuous pattern of labeling for occludin. The immunolabeled 
images suggested a concentration dependent effect on the localization of the junctional proteins 
such as occludin and ZO-1. The immunolabeling results suggest that the distribution of the 
junctional proteins is altered. The decreased immunoreactivity at the apical junction could be due 
to change in localization or reduction in the overall abundance of these proteins.  
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Figure 3.4: NC-1059 decreases ZO-1 and occludin immunoreactivity as a function of time 
and concentration. 
A) Time course of the effects of NC-1059 on ZO-1 and occludin localization. Monolayers 
exposed to Ringer solution only for 30 min or to Ringer solution and 200 μM NC-1059 for 5, 15, 
30 or 60 min were labeled with anti-ZO-1 (red, top panel) and anti-occludin antibodies (green, 
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middle panel). NC-1074 is a peptide that has no effect on transepithelial resistance and is used as 
a negative control. The bottom panels show the merged image with labeling for the nucleus in 
blue. B) Concentration dependent effects of NC-1059 on occludin and ZO-1 localization. 
Monolayers were exposed to vehicle or exposed to 100 or 200 μM NC-1059 for 30 and 60 min 
and subsequently labeled with anti-ZO-1 (red, top panel) and anti-occludin (green, middle panel) 
antibodies. All images were obtained as Z-stacks using confocal microscopy. Images shown are 
the 3-D projection of the respective Z-stacks. In both figures the results are a typical 
representation of n=4 and results presented represent data from paired monolayers. 
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NC-1059 decreases the occludin and ZO-1 cellular abundance in a concentration dependent 
manner: Immunoblotting was used to quantify the effect of 100 and 200 μM NC-1059 on the 
abundance of occludin and ZO-1. Fig. 5A is a typical immunoblot of protein extracted after 
apical exposure to 100 or 200 μM NC-1059 or vehicle for 30 or 60 min and labeled with anti 
ZO-1 antibodies. Immunoblotting showed a decrease in the intensity of ZO-1 bands, after 60 min 
of NC-1059 exposure relative to vehicle only. The average ZO-1 levels normalized to GAPDH, 
which was used as a loading control, are presented in Fig. 5B. The results showed a 
concentration dependent decrease in ZO-1 immunoreactivity after 30 min that was reduced 
further after 60 min of NC-1059 exposure. The intensity of vehicle exposed ZO-1 bands was 
comparable after 30 and 60 min. The loss of ZO-1 immunoreactivity was greater with 200 μM 
NC-1059 as compared to 100 μM NC-1059.  
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Figure 3.5: NC-1059 decreases cellular abundance of ZO-1 in a time and concentration 
dependent manner. 
A) Typical immunoblot showing ZO-1 protein levels in monolayers that were exposed to vehicle 
or 100 or 200 μM NC-1059 for 30 or 60 min. B) Average ZO-1 immunoreactivity determined by 
densitometry and normalized to intensity of the corresponding GAPDH, in monolayers that were 
exposed to vehicle or 100 or 200 μM NC-1059 for 30 or 60 min (results are summarized from 
n=3).  
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A typical immunoblot (Fig. 6A) reveals a decrease in occludin immunoreactivity after 60 
minutes of exposure to 100 and 200 μM NC-1059 relative to monolayers exposed to vehicle only 
for the same period of time. The intensity of the bands in the case of NC-1059 exposed 
monolayers decreased after 30 minutes and showed further reduction at 60 min as compared to 
vehicle treated. The immunoblot reveals a time and concentration dependent effect of the peptide 
on occludin immunoreactivity. The summarized results (Fig. 6B) show a 2 to 3 fold decrease in 
the occludin immunoreactivity, after 30 min of exposure to 100 or 200 μM NC-1059, which is 
reduced further after 60 min. The results show a trend that is consistent with time and 
concentration dependent changes in cellular occludin abundance after exposure to NC-1059. 
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Figure 3.6: NC-1059 decreases cellular abundance of occludin in a time and concentration 
dependent manner. 
A) Typical immunoblot showing occludin protein levels in monolayers that were exposed to 
vehicle or 100 or 200 μM NC-1059 for 30 or 60 min. B) Average immunoreactivity of occludin 
was determined by densitometry and normalized to corresponding GAPDH intensity in 
monolayers that were exposed to vehicle or 100 or 200 μM NC-1059 for 30 or 60 min (results 
are summarized from n=3). 
 
Monolayers recover gte and localization of tight junction proteins: The gte of MDCK monolayers 
treated with 100 μM NC-1059 was observed to return to pretreatment levels 48 hours after 
exposure (1). Hence experiments were conducted to compare the pattern of recovery in gte in 
monolayers treated with 100 and 200 μM NC-1059. Additionally, monolayers treated with 200 
μM NC-1059 were labeled with anti-occludin and anti-ZO-1 antibodies to correlate the recovery 
in gte with localization of junctional proteins. 
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The increase in gte observed upon exposure to 100 and 200 μM returned to pretreatment levels 
over duration of 48 hours (Fig. 7). Monolayers were exposed to 100 or 200 μM NC-1059, or 
vehicle for 60 minutes. Monolayers were then placed back in typical culture conditions for 24 or 
48 hours. The results summarized from 3 experiments showed a significant increase in gte after 
exposure to 100 or 200 μM for 60 min. The change in gte in the presence of 200 μM NC-1059 
was four fold greater than with 100 μM. In monolayers exposed to 100 μM and recovered for 24 
hours there was a 87% recovery in the gte towards pretreatment levels. gte recovered by at least 
90% in the case of the 200 μM exposed monolayers. However in both cases, the gte still remained 
significantly greater than pretreatment. In 48 hours the gte decreased further. The majority of the 
recovery occurs within 24 hours and after 48 hours, the values are not significantly different 
from pretreatment.  
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Figure 3.7: Monolayers exposed to 100 and 200 μM NC-1059 recover to pretreatment gte 
within 48 hours. 
Recovery in gte after exposure to 100 μM (A) or 200 μM (B) NC-1059. Monolayers were 
exposed to vehicle or NC-1059 for 60 min in the Ussing chamber and returned to the incubator. 
gte was subsequently measured after 24 hours and 48 hours post treatment for each pair (vehicle 
and NC-1059 treated) of monolayers and results are summarized from n = 3 (* p<0.05). 
 
 
Occludin and ZO-1 are localized at the tight junctions within 24 hours following exposure to 
NC-1059. The localization pattern after 48 hours is indistinguishable from vehicle treated 
monolayers (Fig. 8). MDCK monolayers that were exposed to vehicle show that occludin and 
ZO-1 are localized as expected along the apical region of cell-cell contacts. MDCK monolayers 
that were exposed to 200 μM NC-1059 for 60 min showed reduced ZO-1 and occludin 
immunoreactivity along the apical cell-cell contacts. NC-1059 treated monolayers that were 
recovered for 24 hours showed greater intensity of the ZO-1 labeling at the tight junctions 
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similar to vehicle treated conditions. The intensity of occludin labeling was also recovered as 
compared to treatment with NC-1059 at 60 min but appeared to be less pronounced as compared 
to the vehicle exposed monolayers. After 48 hours, ZO-1 immunolabeling showed a pattern and 
intensity comparable to control conditions, which suggests that localization of ZO-1 to the tight 
junctions was fully restored. Occludin localization along cell-cell contacts also appeared to be 
more pronounced after 48 hours of recovery. 
 
 
 
Figure 3.8: Immunoreactivity of occludin and ZO-1 at the tight junctions recovers within 
24 hours. 
Monolayers exposed to vehicle or 200 μM NC-1059 for 60 min. Monolayers were either fixed at 
60 min or returned to the incubator for 24 or 48 hours, and fixed subsequently. Monolayers were 
then labeled with anti-occludin (green) and anti-ZO-1 (red) antibodies. Images were obtained as 
Z-stacks using confocal microscopy. Images shown above are the 3-D projection of the 
respective Z-stacks. Results are a typical representation of n=2.. 
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NC-1059 alters the distribution of E-cadherin and β-catenin: NC-1059 caused a decrease in 
immunoreactivity of the adheren junction proteins E-cadherin and β-catenin (Fig. 9). Monolayers 
were exposed to 200 μM NC-1059 or vehicle (Ringer solution) for 30 or 60 minutes. Monolayers 
were subsequently fixed and labeled with anti-E-cadherin and anti-β-catenin antibodies. An 
orthogonal view showing the central optical slice (0.8 μM) and labeling along the x and y axis is 
presented for each condition. Monolayers that were vehicle treated for 30 or 60 minutes showed 
a reticular pattern of labeling along cell-cell contacts for E-cadherin and β-catenin, which is 
consistent with the localization of these proteins at the adheren junction. Exposure to 200 μM 
NC-1059 for 30 min resulted in decreased immunoreactivity of both E-cadherin and β-catenin 
and the labeling pattern appeared to be diffuse. After 60 minutes of exposure to 200 μM NC-
1059, immnuoreactivity of E-cadherin and β-catenin was diminished further.  
 112
 
 
 
Figure 3.9: NC-1059 alters distribution of distribution of E-cadherin and β-catenin. 
A) Monolayers were exposed to 200 μM NC-1059 or vehicle (Ringer solution) for 30 or 60 
minutes and labeled with anti-E-cadherin (red, top panel), and anti-β-catenin (red, bottom panel) 
antibodies. Images are presented as an orthogonal view showing a single optical slice (0.8 μM) 
of the Z-stack and the labeling along x and y axis. Results are typical of n=2.  
 
 
NC-1059 alters abundance of junctional proteins: NC-1059 reduced the cellular abundance of 
junctional proteins, E-cadherin and also has a modest affect on β-catenin abundance. Typical 
immunoblots of monolayers exposed to vehicle, 100 and 200 μM NC-1059 for 30 or 60 minutes 
and immunolabeled for E-cadherin and β-catenin, are represented in Fig. 10. A reduction in 
intensity of the E-cadherin after exposure to 100 and 200 M NC-1059 is observed after 60 min 
(Fig. 10A). The decrease in intensity appears to be greater with 200 μM NC-1059. Additionally a 
faint ~80 kDa band is observed that might be a breakdown product of E-cadherin. There is no 
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visually discernable effect of NC-1059 in the intensity of the bands as compared to vehicle 
treated monolayers in typical immunoblots shown for β-catenin (Fig. 10B). Nonetheless the 
effect on cellular abundance of β-catenin (Fig. 10B) is modest with a decrease in 
immunoreactivity seen only at 60 minutes which is less than 2 fold as compared to vehicle 
treated. The abundance of E-cadherin decreases with time and shows a concentration dependent 
trend (Fig. 10A). A 2 fold difference in E-cadherin immunoreactivity is observed after 60 min of 
NC-1059 exposure.  
 
 
Figure 3.10: NC-1059 affects cellular abundance of E-cadherin and β-catenin. 
Typical and summarized results from immunoblots of monolayers exposed to vehicle, 100 or 200 
μM NC-1059 for 30 or 60 min and labeled for A) E-cadherin or B) β-catenin is shown above. 
(Results are summarized from n=3). 
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Discussion:  
The results demonstrate that the NC-1059 induces an increase in paracellular permeability that is 
associated with a change in organization of the actin cytoskeleton and a decrease in abundance of 
occludin and ZO-1 at the tight junctions. NC-1059 enhances gte and solute permeability through 
a paracellular route in MDCK monolayers in a concentration dependent manner. The effects of 
NC-1059 on gte and localization or abundance of the junctional proteins are transient insofar as 
the gte and localization of junctional proteins showed substantial recovery within 24 hours and 
complete recovery in 48 hours. 
Apical exposure to NC-1059 caused a large increase in gte in a concentration dependent manner. 
The rate of change in gte and maximal gte were significantly greater with 200 μM NC-1059 
compared to 100 μM NC-1059. Previous studies showed that 60 μM NC-1059 enhanced 
permeability to dextran although 60 μM did not enhance passage of dextrans as large as 77 kDa 
(1). However current results show that 200 μM NC-1059 enhanced the permeation of both 40 
and 70 kDa dextran several fold as compared to untreated monolayers. Permeation across 
epithelial barriers is the rate limiting step in the delivery of many drugs and since NC-1059 can 
enhance permeation of molecules as large as 70 kDa, it might provide the opportunity to develop 
a co-therapeutic to enhance localized delivery of several antibiotics and especially antivirals 
which are typically larger. 
Apical exposure to 200 μM NC-1059 caused a reorganization of actin that was detectable as 
early as 15 min after exposure. There was a pronounced decrease in the intensity of labeling of 
F-actin after 30 min of NC-1059 exposure. Actin reorganization with both 100 and 200 μM NC-
1059 followed a similar time course. F-actin is the polymerized form of actin and G-actin is the 
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monomeric form. The polymerization is a reversible reaction and the two forms exist in 
equilibrium at a critical concentration of G-actin (17). Loss of F-actin labeling suggests that there 
might be an NC-1059 induced depolymerization of F-actin. This could be due to an increase in 
the rate of depolymerization or destabilization of the F-actin structure as is the case with 
compounds such as cytochalasin (17). Based on observations under physiological conditions, it 
was proposed that the contraction of the perijunctional actomyosin ring might play a role in 
enhancing permeability through the paracellular route (18, 34). Extracellular molecules such as 
cytochalasins (19), protamines (25) and ZOT (9) are among several molecules that have been 
observed to enhance permeability by altering the organization of actin and specifically the 
perijunctional actomyosin ring. The NC-1059 induced increase in gte is associated with the 
rearrangement of actin, which might be a common mechanism associated with increase in 
paracellular permeability. 
NC-1059 treated MDCK monolayers show reduced immunoreactivity to antibodies against 
occludin and ZO-1, which suggests that NC-1059 causes a change in the distribution or 
expression of occludin and ZO-1. The distribution of ZO-1 appears to be altered to larger extent 
by 200 μM NC-1059 than by 100 μM NC-1059 at the 30 minute time point. There is little change 
in occludin at 30 min. Western blotting indicates NC-1059 decreases protein levels of both 
occludin and ZO-1, which likely reflects enhanced breakdown or reduced synthesis in the 
junctional proteins. The loss of ZO-1, as indicated by immunoblotting also follows a 
concentration dependent trend. ZO-1 is a MAGUK protein that has several protein-protein 
interaction domains and hence serves as a scaffold for the interaction of junctional proteins and 
the actin cytoskeleton (7, 11). ZO-1 interacts with occludin through its GUK domain and with 
actin through its C-terminus (12, 16). Additionally occludin interacts with actin directly (24). 
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Hence the NC-1059 mediated change in actin organization might cause in the loss of localization 
of occludin and ZO-1 at the tight junctions through its direct and indirect interactions with these 
proteins leading to disruption of barrier integrity.  
NC-1059 has an effect on distribution and cellular abundance of the adheren junction proteins, 
E-cadherin and β-catenin. Although the intensity of β-catenin localized at the adheren junctions 
is diminished, the effect of NC-1059 on overall abundance is modest. This suggests that, the 
protein might be accumulating in the cytosol. Immunoblot of E-cadherin shows the appearance 
of a single breakdown product suggesting that E-cadherin is cleaved by a specific protease. 
Breakdown of E-cadherin has been reported in the case of ATP depletion (4) and also implicated 
in the effects on paracellular permeability by the zinc metalloprotease, Bacteroides fragilis toxin 
(27, 37) The detection of an 80 kDa fragment is unusual since metalloproteases cause 
ectodomain shedding with loss of the 80 kDa fragment and detection of only a 30-40 kDa 
fragment in other systems (38). Nevertheless the results are consistent with a protease activity. 
The effect of NC-1059 is transient. Despite the loss of F-actin, especially in the basal region of 
the cells, the monolayers remained adherent and the gte recovered to pretreatment levels within 
48 hours. After 24 hours there was obvious recovery of ZO-1 localization to the cell periphery in 
the monolayers and occludin also recovered, although to a lesser extent. Recovery could involve 
either synthesis of new protein or recruitment from a preexisting or recycling pool. The reduction 
in overall immunoreactivity in western blots argues against recycling of protein. Moreover the 
recovery in gte to pretreatment values requires more than 24 hours, which suggest that recovery 
might require synthesis and assembly of the junctional proteins. Localization of junctional 
proteins after 48 hours is comparable to untreated monolayers. ZO-1 is proposed to be an early 
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player in the assembly of junctional proteins (21). Hence recovery in ZO-1 might be significant 
in the recovery of gte.  
The transient effect of NC-1059 on modulating barrier function is particularly significant in 
developing a co-therapeutic to enhance delivery of drugs across epithelial barriers. “Absorption 
enhancers” are being developed to deliver clinically relevant therapeutics across epithelial 
barriers. Molecules that are hydrophilic and or large in size cannot easily permeate epithelial 
barriers. Systemic drug delivery requires larger doses of drugs and is therefore associated with 
potential side effects (33). Several barrier epithelia such as intestinal, airway and corneal / 
conjuctival epithelia are potential targets for localized drug delivery (6, 13). Results presented in 
this paper show that NC-1059 enhances the permeation of molecules as large as 70 kDa across 
MDCK epithelial monolayers. The effects on permeability can be generalized to several other 
epithelial cell lines derived from a variety of sources (30). NC-1059 reversibly alters the 
organization of actin and localization of junctional proteins, which may account for the enhanced 
permeability. Hence NC-1059 has potential to be developed as an absorption enhancer for 
therapeutic agents.  
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  Summary and Conclusions 
NC-1059 is a synthetic channel forming peptide that reversibly modulates epithelial barrier 
function. Therefore it has potential to be developed into a co-therapeutic that can enhance the 
absorption of drugs in a localized manner across epithelial barriers. 
NC-1059 increased short circuit current (Isc) and transepithelial conductance (gte) in a 
concentration dependent manner across several epithelial monolayers. The changes in the 
electrical parameters are consistent with the association of NC-1059 with the membrane to form 
ion channels that result in an increase in anion secretion or cation absorption. The increased gte 
also suggest an effect on paracellular conductance. Although the effects of NC-1059 varied 
depending upon cell type, these results suggest that NC-1059 can alter the electrical properties of 
most epithelia. 
The effect of NC-1059 on gte is accompanied by an increase in paracellular permeability. 
Although there is no clear correlation between the paracellular permeability and gte, it appears 
that a large increase in gte results in a significant increase in permeability even of large dextrans. 
Dextran permeability is enhanced to varying extents in different epithelia. Also, permeability is 
size dependent and size selectivity is maintained after NC-1059 exposure but not after exposure 
to EDTA. EDTA is reported to cause a pronounced disruption of the junctional proteins. Based 
on the differences in permeability, it is clear that the mechanisms that mediate the effects of NC-
1059 are less disruptive than EDTA and probably involve select junctional proteins. 
NC-1059 is distinct from zona occludens toxin (ZOT) in that the effects of ZOT are reportedly 
limited to certain epithelia. ZOT and compounds derived from ZOT such as ΔG lack activity in 
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colon (Di Pierro et al., 2001; Fasano et al., 1995). NC-1059 has significant effects on a colonic 
cell line (T-84). This suggests that NC-1059 might be useful in enhancing permeability across 
epithelia, separate from already discovered compounds. 
The effects on paracellular permeability suggested a mechanism that includes changes in the 
organization of molecules that compose or regulate the tight junctions. NC-1059 induced 
increases in gte and permeability are accompanied by a reorganization of actin, which begins 
within the first 15 minutes of exposure and pronounced effects are observed in less than 60 
minutes. NC-1059 also affects distribution and abundance of tight junction proteins occludin and 
ZO-1. There is a pronounced effect on ZO-1 localization and these effects follow a similar time 
course as F-actin disruption. NC-1059 has an effect on the distribution and cellular abundance of 
the adheren junction proteins, E-cadherin and β-catenin. NC-1059 causes a time and 
concentration dependent decrease in the abundance of E-cadherin, with immunoblots suggesting 
a possible breakdown of E-cadherin.  
It is clear that breakdown of E-cadherin, redistribution of β-catenin, F-actin rearrangement and 
disruption of tight junction proteins ZO-1 and occludin are inter-related events and are either 
regulated by identical mechanisms or pathways with significant cross talk.  Taken together the 
results suggest that NC-1059 mediated increase in paracellular permeability might activate 
biochemical pathways common to several molecules that modulate barrier function. Small G 
proteins have a significant role in regulating F-actin organization and junctional proteins. The 
reorganization of actin accompanied by disruption of tight junction proteins caused by activation 
or inactivation of Rho and Rac also affects localization of E-cadherin in MDCK monolayers 
(Jou, Schneeberger & Nelson, 1998). It is possible that the reorganization of actin and possibly 
subsequent loss in junctional proteins induced by NC-1059, could involve Rho/Rac activity.  
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The most significant observation is that the effects of NC-1059 on epithelial permeability are 
reversible. The majority of the gte recovers within 24 hours along with the localization of 
junctional proteins particularly ZO-1. ZO-1 is involved in tight junction assembly and hence 
localization of ZO-1 at the tight junctions suggests reassembly of the tight junctions. In studies 
where E-cadherin was degraded as seen with ATP depletion or Bacteroides fragilis toxin (BFT), 
the effects were reversible and synthesis of E-cadherin was involved in recovery (Wu et al., 
1998; Wu et al., 2006). The reversible modulation of the junctional proteins that enhances 
paracellular permeability is an encouraging discovery in the development of an absorption 
enhancer. 
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